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ABSTRACT

The ontogeny of dopamine-mediated motor systems has
not been thoroughly investigated in young animals.

It has

generally been shown that preweanling and adult rats
respond similarly to dopaminergic compounds;

however,

some

behaviors vary across ontogeny due to maturational changes
in dopamine systems.

2-dihydroquinoline

antagonist,

N-ethoxycarbonyl-2-ethoxy-l,

(EEDQ) ,

an irreversible receptor

has been used to study the ontogeny of

dopamine receptor functioning.

Systemic administration of.

EEDQ attenuates dopamine agonist-induced behaviors of
adult rats,

while leaving the behaviors of young rats

■unaffected.

The purpose of this thesis was to:

a)

investigate' the effects of intrastriatally administered

EEDQ on NPA-induced locomotor activity in preweanling and

adults rats; b)
' (Dl- or D2-like)

determine which dopamine receptor subtype
is responsible for modulating EEDQ's

paradoxical behavioral effects in preweanling rats;

c)

and

examine the magnitude of EEDQ-induced Dl- and D2-like

receptor inactivation in both adult and preweanling rats.

In Experiment 1,

EEDQ or DMSO were bilaterally infused

into the dorsal striatum on PD 84. After 24 hr,

rats were

given bilateral microinjections of the full dopamine

agonist R (--■)-propylnorapomorphine

(NPA)

or distilled water

and locomotor activity was assessed for 40 min.

Experiments 2 and 3,

preweanling rats

in the same manner as adults,

and D2-like receptors

(PD 17)

In

were treated

with the exception that Dl-

(either alone or in combination)

were protected from EEDQ-induced alkylation by pretreating

rats with a Dl- and/or D2-like receptor antagonist. As
expected,

infusing EEDQ into the dorsal striatum

attenuated the NPA-induced locomotor activity of adult
rats.

Conversely,

preweanling rats given bilateral EEDQ

infusions on PD 17 exhibited a potentiated locomotor
response when treated with NPA.

Experiments 2 and 3 showed

that dopamine receptor inactivation was responsible for
the exaggerated locomotor response to NPA.

Specifically,

NPA-induced locomotor potentiation was not evident if both
DI- and D2-like receptors were protected from EEDQ-induced

receptor alkylation.

In Experiments 4 and 5,

homogenate

ligand binging and autoradiography assays showed that EEDQ

significantly reduced DI- and D2-like receptor levels in

both preweanling and adult rats. A plausible explanation
for these results is that a receptor reserve,

or the lack

thereof, may account for the qualitatively different

patterns of NPA-induced locomotor activity exhibited by
EEDQ-treated preweanling and adult rats. Alternatively,
the potentiated locomotor response exhibited by

iv

preweanling rats may be caused by receptor

supersensitivity resulting from EEDQ treatment.

It is

possible that adult rats do not show potentiated locomotor
activity because EEDQ does not produce a similar change in
receptor dynamics.

v
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CHAPTER ONE

BASAL GANGLIA

Introduction

The basal ganglia is important for the initiation of

motor movements and responses,

although it is also

implicated in drug-seeking behavior as well as cognition,
and memory

emotion,

Schneider,

Brown,
Hall,

& Everitt,

Phillips & Carr,
Salinas,

2003).

(Alcaro,

& Lidsky,

Huber,

1987;

Cardinal,

1997;

2002; Nicola,

& Panksepp,

2007;

Parkinson,

2000;

Surmeier & Malenka,

Schultz,

1994; White,

1997; White &

The basal ganglia is involved in various

aspects of motor control including the initiation and
execution of movements

Evarts,

Teravainen,

(Denny-Brown & Yanagisawa,

& Caine,

sequencing of movements

1981;

(Schwab,

Flowers,

Chafetz,

automatic execution of routine movements

1976;

1976),

& Walker,

1954),

(Marsden & Obeso,

1994),

and inhibition of competing motor programs

1996).

In terms of motor control,

(Mink,

the basal ganglia is

composed of several interconnected nuclei located in the
telencephalon,

diencephalon,

and midbrain

(Hauber,

1998).

Structures that comprise the basal ganglia include the

striatum,

globus pallidus,

entopeduncular nucleus,

subthalamic nucleus,

and substantia nigra

1

(Figure 1).

Basal Ganglia

GAGA

Figure 1. The Circuitry of the Basal Ganglia. GABAergic
Fibers Descend from the Dorsal Striatum and Project to the
Substantia.Nigra pars Reticulata and Entopeduncular
Nucleus via the Direct (striatonigral) Pathway and to the
Globus Pallidus and, Subsequently, to the Substantia Nigra
pars Reticulata and Entopeduncular Nucleus by way of the
Subthalamic Nucleus via the Indirect (striatopallidal and
striatoentopeduncular) Pathway. GP, globuspallidus; SU,
subthalamic nucleus; EN, entopeduncular nucleus; SNPR,
substantianigra pars reticulata, SNPC, substantianigra
pars compacta; DA, dopamine; GLU, glutamate; SP, substance
P; Ach, acetylcholine. Adapted and modified from
Charntikov (2009).

(2009) Role of dorsostriatal DI and 02
receptors in in modulating the kappa opiood-mediated
locomotor activity of preweanling rats:, importance of
synergistic activation (Unpublished master's thesis).

Charntikov, S.

Available from California State Universty, San
Bernaridino.

2

Two notable neurodegenerative diseases that arise from
'basal ganglia _dysfunction are Parkinson's disease and
Huntington's chorea

(Albin,

Young,

& Penney,

1989).

Overview of Basal Ganglia Circuitry

The striatum is the major input structure of the
basal ganglia.

It receives afferents from the entire

cerebral cortex and relays these signals to the
entopeduncular nucleus and substantia nigra pars

reticulata

ganglia)
1998).

(i.e.,

the two major output nuclei of the basal

via the direct and indirect pathways

(Hauber,

The globus pallidus and subthalamic nucleus

(integral parts of the indirect pathway)

process and

transfer signals from input structures to output

structures
1982).

(Carter & Fibiger,

1978;

DeVito & Anderson,

Efferents from output structures project to motor

nuclei of the brainstem and to motor association cortex

via the thalamus

(Hauber^

1998).

Striatum

The caudate and putamen are collectively referred to
as the dorsal striatum.
the ventral striatum),

dorsal striatum,

striatum.

The nucleus.accumbens

(also called

located rostro-ventrally to the

is the other major component of the

The major input to the striatum is via

3

excitatory glutamatergic projections from the cerebral

GABAergic medium spiny neurons,

cortex.

which constitute

approximately 90-95% of all striatal neurons in rodents,

are segregated in different compartments within the
striatum

(Gerfen,

1985;

Herkenham,

& Bolam 1987;

Edley,

& Stuart,

1984;

Izzo,

Graybiel,

Penny, Afsharpour,

& Kitai,

1984)

and contain both Dl- and D2-like receptors

(Chang &

Kitai,

1985;

Deniau,

Vacher,

1990;

Emson,

Chang,

Wilson,

& Kitai,

1982;

1985; Kawaguchi,

& Desban,

Kita & Kitai,

1988).

Chevalier,

Wilson,

&

Descending GABAergic

fibers project to the substantia nigra pars reticulata and

entopeduncular nucleus via the direct pathway; whereas,
GABAergic neurons projecting to the globus pallidus

striatopallidal pathway)

(i.e.,

comprise the first segment of the

indirect pathway.

Dopaminergic neurons provide the most important
modulatory input to the striatum.

Striatonigral and

striatoentopeduncular neurons of the direct pathway
prominently express Dl-like receptors

Gerfen,
Rees,

Keefe,

Heilman,

& Gauda,

Yung,

1995; Hersch,

Bolam,

Ince,

Yi,

(Gerfen,

Ciliax,

1995; Le Moine, Normand,

& Bloch,

and co-release GABA,

dynorphin

1990)

(Beckstead,

1985;

1995;

Guitteny,

substance P,

Kanazawa,

4

Gutekunst,

& Levey,

Moine & Bloch,

1992;

Emson,

Le

Teoule,
and

& Emson,

199.7; ' Vincent,

Hdkfe.lt,

Christensson,

& Terenius,

1982) .

striatopallidal neurons, which are the

•In contrast,

initial neurons of the indirect pathway, prominently
express D2-like receptors
1995; Hersh et al.,

et al.,

1990)

(Beckstead,
1982).

(Gerfen,

1992;

Gerfen et al.,

1995; Le Moine & Bloch,

1995; Le Moine

and co-release GABA and enkephalin

1985;

Kanazawa et al.,

1997; Vincent et al.,

Even though Dl-like receptor stimulation activates

the direct pathway and D2-like receptor stimulation

inhibits the indirect pathway,

there appears to be a small

degree of receptor co-lbcalization on these descending

neurons

(Aizman,

Forssberg,.

Brismar,

Greengard,

Uhlen,

& Aperia,

Surmeier,

Eberwine, Wilson,

Surmeier,

Reiner,

& Yan,

Levine,

Cao,

Settergren,

2000;

Hersch et al.,

Stefani,

& Ariano,

Levey,

1993;

& Kitai,

1995;

1992;

Surmeier,

Song,

1996).

Striatal neurons are primarily modulated by
dopaminergic input; however,

these dopaminergic effects

can be further modulated by other neurotransmitters.

example,

For

adenosine regulates the functional properties of

dopamine receptors by interacting with G protein-coupled
adenosine receptors. Adenosine Ai receptors are

co-localized on neurons of the direct pathway containing

Dl-like receptors

(Ferre,

O'Connor,

5

Svenningsson,

Bjorklund, Lindberg, Tinner, Stromberg, Goldstein, Ogren,

Ungerstedt,

Fredholm,

1996) , while adenosine A2a'

& Fuxe,

receptors are co-localized on neurons of the indirect
pathway containing D2-like receptors

& Vanderhaeghen,

(Schiffmann, Jacobs,

1991). The functional significance of

this co-localization suggests an antagonistic interaction
between striatal adenosine receptors and dopamine

receptors

(Ferre et al.,

Ungerstedt,

1996; Ferre, O'Connor,

Fuxe,

&

1993).

The serotonergic, noradrenergic, and cholinergic

neurotransmitter systems also modulate striatal

Serotonergic inputs from the dorsal

neurotransmission.

nucleus of the raphe and caudal linear nucleus project
densely to the striatum,

substantia nigra, and globus

pallidus

(Imai, Steindler,

Hattori,

1980; Vertes,

Harding,

& Paxinos,

& Kitai, 1986; Van der Kooy &

1991; for a review,

see Halliday,

1995). Several serotonin receptor

subtypes are co-localized with striatal enkephalin,
substance P, and dynorphin receptors

(Ward & Dorsa, 1996).

Noradrenergic fibers originating in the locus coeruleus
project to the striatum and alter signal processing

(Marien, Letagan,

1994), while cholinergic

& Colpaert,

interneurons within the striatum modulate the activity of

6

the direct and indirect pathways

Console*,

(Di Chiara,

Morelli,

&

1994) .

Globus Pallidus
The globus pallidus receives substantial input from
the dorsal striatum via striatopallidal neurons of the

These striatopallidal projections

indirect pathway.

co-release GABA and enkephalin

Grofova,

1978).

(Fonnum,

&

Gottesfeld,

The globus pallidus also receives

glutamatergic input from the subthalamic nucleus. Axonal

collaterals from the. substantia nigra pars compacta
provide dopaminergic innervation to the globus pallidus

(Lindvall & Bjorklund,

1979).

The globus pallidus

expresses DI- and D2-like receptors

Penny,

1987;

kainate,

Yung et al.,

(Richfield,

Hollingsworth,

Dure,

&

as well as NMDA, AMPA,

1995),

and metabotropic glutamate receptors

Mzrcowiec,

Young,

Penny,

(Albin,

& Young,

1992) .

Pallidal projections send inhibitory GABAergic
signals to the dorsal striatum,

pedunculopontine nucleus,

substantia nigra,

reticular thalamic nucleus

& Anderson,

Kincaid,
1991;

(Carter & Pycock,

Fonnum et al.,

1982;

Penney,

subthalamic nucleus,

Young,

Parent & Hazrati,

der Kooy & Carter,

& Newman,
1995;

1981),

and the
1978;

1978; Grofova,

DeVito

1975;

1991; Kita & Kitai,

Staines & Fibiger,

1984; Van

as well as sending cholinergic

7

and noncholinergic signals to the cortex
Alheid,

1995).

Zahm,

(Heimer,

&

The globus pallidus controls basal ganglia

output via multiple direct and indirect connections to

Therefore,

various basal ganglia nuclei.

the globus

pallidus is more than just a relay station transferring
signals between the striatum

(input structure)

and the

entopeduncular nucleus and substantia nigra pars
reticulata

(output structures)

(Chesselet & Delfs,

1996).

Subthalamic Nucleus

The subthalamic nucleus receives prominent

glutamatergic excitatory input from the frontal cortex

(Canteras,

Shammah-Lagnado,

Silva,

& Ricardo,

Fujimoto & Kita,

1993)

pallidus

1981; Vincent et al.,

(Feger,

thalamic nuclei
brainstem nuclei
raphe)

1983).

and GABAergic input from the globus
1982).

1994;

Certain

(centromedian and parafascicular)

and

(pedunculopontine tegmental and dorsal

innervate the subthalamic nucleus

Crossman,

1990;

Sugimoto,

Hattori,

(Feger,

Mizuno,

Itoh,

Bevan, •&
& Sato,

Some evidence suggests the existence of

dopaminergic inputs from the substantia nigra pars
compacta

Breese,

(Fremeau,
& Caron,

Duncan,

1991;

Fornaretto,

Hassani,

1997) .

8

Dearry,

Francois,

Gingrich,

Yelnik,

& Feger,

The subthalamic nucleus sends excitatory

(glutamatergic)

signals to the globus pallidus,

and substantia nigra pars

entopeduncular nucleus,

reticulata

(Hammond,

Nakanishi,

Kita,

Deniau,

& Kitai,

Rizk,

1987).

& Feger,

1978;

Subthalamic efferents

also project to the dorsal striatum and the
pedunculopontine tegmental nucleus

1992; Takada,

Nishihama,

der Kooy & Hattori,

(Moriizumi & Hattori,

Nishihama,

& Hattori,

1988; Van

1980).

Substantia Nigra Pars Reticulata

The substantia nigra consists of two nuclei

(pars

and is located in the

compacts'and pars reticulata)

tegmentum of the midbrain. Along with the entopeduncular

nucleus,

the substantia nigra pars reticulata

(i.e.,

the

two major output structures of the basal ganglia)
integrates and conveys incoming signals to thalamic and

midbrain nuclei.

The substantia’ nigra pars reticulata

receives inhibitory GABAergic input from the dorsal
striatum,

1990;

via the direct pathway

Deniau,

Hammond,

nucleus accumbens

Riszk,

(Deniau,

(Chevalier & Deniau,

& Feger,

Menetrey,

1978),

and from the

& Thierry,

1994).

The

substantia nigra pars reticulata receives excitatory

glutamatergic input from the subthalamic nucleus via the

9

indirect pathway (Hammond et. al.,

1978; Nakanishi et al.,

198'7).

As just described,

an important convergence occurs in

the substantia nigra pars reticulata.
‘from the dorsal striatum

the direct pathway)

(i.e.,

globus pallidus/subthalamic nucleus
pathway)

Efferents projecting

(i.e.,

and

the indirect

converge onto single neurons of the substantia

nigra pars reticulata and allow for an integration of

neural processing
Smith,

1993).

(Bolam,

Smith,

Ingham,

Von Krosigk,

&

The substantia nigra pars reticulata sends

GABAergic output from the basal ganglia to the thalamus,

superior colliculus,

(Beckstead,
1992;

Domesick,

Gerfen,

Kitai,

1987;

and pedunculopontine nuclei

Staines,

& Nauta,

1979;

Arbuthnott,

Nakanishi et al.,

Deniau & Chevalier,

& Fibiger,

1987).

1982;

Kita &

The thalamus then

provides Input to the frontal cortex and the dorsal

striatum

(Hauber,

1998).

Entopeduncular Nucleus
The entopeduncular nucleus Is the smallest basal

ganglia structure and,
pars reticulata,

ganglia.

along with the substantia nigra

is a major output structure of the basal

Like the substantia nigra pars reticulata,

the

entopeduncular nucleus receives GABAergic inhibitory
innervation from the striatum

10

(Fonnum et al.,

1978; Nagy,

& Fibiger,

Carter,

1978;

Smith & Parent,

1988)

and

excitatory innervation from the subthalamic nucleus
& Kitai,

1987;

1987;

Parent & Smith,

Smith & Parent,

1988).

(Kita

1987; Nakanishi et al.,

The substantia nigra pars

compacta sends dopaminergic input to the entopeduncular

nucleus

(Lindvall & Bjorklund,

1979). GABAergic efferents

project from the entopedundcular nucleus
to the thalamus

1994)

Kooy & Carter,
1979),

Mizuno,

1981),

(Carter & Fibiger,

(Joel & Weiner,
1978; Van der

pedunculopontine nucleus

and superior colliculus

(Takada,

(Nauta,

Tokuno,

Ikai,

&

1994)..

Substantia Nigra Pars Compacta

The substantia nigra pars compacta is a dopamine-rich

nucleus that sends projections to the dorsal striatum
(nigrostriatal pathway),

subthalamic nucleus

(nigrosubthalamic pathway),

(nigropallidal pathway),
brain areas.

and globus pallidus

and receives input from multiple

Dopamine cell bodies in an associated

midbrain structure,

the ventral tegmental area, project to

the ventral striatum (also called the nucleus accumbens).

Interestingly,

dopaminergic neurons in the substantia

nigra pars compacta have a distinguishing feature in that

they are able to synthesize,

store,

at the somatodendritic level

(Bustos, Abarca,

11

and release dopamine

Campusano,

Bustos,

Noriega,

& Aliaga,

2004).

This feature endows

dopamine neurons with exceptional communicating abilities,

which might contribute to information processing within
the substantia nigra pars compacts

Cuello,
1998;

& Iversen,

Ko-rf,

1976;

Z.ieleman,

& Glowinski,

Cheramy,

Jaffe,

Marty,

& Westerink,

Jessell,

(Geffen,

Schulte,

& Chow,

1976; Nieoullon,

1976).

Dopamine neurons projecting from the substantia nigra
pars compacta synapse on GABAergic neurons of the dorsal

striatum

Dunnett,

(Clarke,

Bjorklund,

Isacson,

Sirinathsinghji,

&

Stimulation of striatal D2-like

1988).

receptors inhibits the indirect pathway; whereas,
stimulation of Dl-like receptors activates the direct
pathway

(Gerfen,

1992). As mentioned previously,

there is

some degree of receptor co-localization on GABAergic

neurons,

because striatonigral neurons express some

D2-like receptors,

while striatopallidal and

striatoentopeduncular neurons express some Dl-like

receptors

(Aizman et al.,

Surmeier et al.,

1992,

2000;

1993,

Hersch et al.,

1995;

1996).

Functioning of the Basal Ganglia

Overview

The basal ganglia is implicated in the initiation of

motor movement as well as other behaviors.

12

The striatum is

the major input structure,

which conveys information to

the substantia nigra pars reticulata and entopeduncular
nucleus via the direct and indirect pathways.

The striatum

receives glutamatergic innervation from the cortex,

and

dopaminergic innervation from the substantia nigra pars

compacts and ventral tegmental area. This dopaminergic
innervation modulates the direct and indirect pathways and
is necessary for intact motor initiation and execution.

Basic Basal Ganglia Functioning

The direct

(striatonigral)

pathway provides direct

inhibitory input to the substantia nigra pars reticulata
and entopeduncular nucleus,

thereby inhibiting GABAergic

neurons projecting to motor nuclei in the thalamus,
superior colliculus,
the direct pathway,

motor movement
'Monsma,

and pedunculopontine nucleus.

by disinhibiting motor nuclei,

(Gerfen,

& Sibley,

Engber,

Mahan,

Susel,

Thus,

permits

Chase,

1990). Activation of the indirect

pathway via glutamatergic input from the cortex stimulates

striatopallidal neurons and disinhibits subthalamic input

to the substantia nigra pars reticulata.

In this way,

the

firing rate of GABAergic nigral output neurons is
intensified and motor nuclei in the thalamus,

colliculus,
inhibited.

superior

and pedunculopontine nucleus are further

In the absence of signal,

13

the substantia nigra

pars reticulata is tonically active and provides

inhibitory input to these motor nuclei,

thus not allowing

movement.
Impact of Dopamine on Basal Ganglia Functioning
Striatal- Dl- and D2-like receptor stimulation alters
the firing rate of GABAergic neurons and indirectly

modulates motor movement.
direct pathway,

Specifically,

activation of the

via Dl-like receptor stimulation,

decreases the firing rate of tonically active substantia
nigra pars reticulata neurons

(Chevalier et al.,

further intensifies on-going motor movements.
of the indirect pathway,

softens

(reduces)

1985)

Inhibition

via D2-like receptor stimulation,

the inhibition of the globus pallidus.

The globus pallidus,

becomes progressively more active and

inhibits the subthalamic nucleus.

This inhibition reduces

excitatory output from the subthalamic nucleus and,
turn,

and

in

reduces the firing -rate of GABAergic nigral output

neurons.

Therefore,

through very different mechanisms,

Dl-

and D2-like receptor stimulation inhibits GABAergic

neurons of the substantia nigra pars reticulata and
permits motor movement.

Behavioral Impact of Basal Ganglia Degeneration

Two very common motor disorders result from the
degeneration of basal ganglia cells:

14

Parkinson's disease

and Huntington's chorea.

Parkinson's disease is

characterized by difficulty in initiating desired motor

movements.

Damage to the substantia nigra pars compacta

leads to the degeneration of the nigrostriatal dopamine

pathway"and,

ultimately,

neurotransmission

a loss of striatal GABAergic

(Albin et al.,

1989;

Barbeau,

1986).

This causes striatal projections to the substantia nigra

(i.e.,

pars reticulata to become less active

loss of Dl-like receptor stimulation),

due to the

while projections

to the globus pallidus become more active

(i.e.,

the loss of D2-like receptor stimulation).

due to

The end result

is increased excitatory input from the subthalamic nucleus
to the substantia nigra pars reticulata and an inhibition

of motor movement.
Huntington's chorea is a disease characterized by an

excess of motor movements and behavior

1989; Martin & Gusella,

1986).

(Albin et al.,

Striatal projections to the

globus pallidus and substantia nigra pars reticulata

degenerate

(Arregui,

Strittmatter,

Lo,

Iversen,

Javitch,

Spokes,

& Snyder,

& Emson,
1984).

1979;

This

degeneration results in a disinhibition of the globus
pallidus,

which causes diminished activity in the

subthalamic nucleus. The lack of excitatory input to the

15

substantia nigra pars reticulata allows an excess of motor
movement to occur.
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CHAPTER TWO
DOPAMINE PHARMACOLOGY

Introduction
Dopamine is a catecholamine neurotransmitter that

controls a variety of functions in the mammalian brain and
periphery (Missale, Nash, Robinson, Jaber, & Caron, 1998).
Dopamine was first synthesized in 1910 by George Barger
and James Ewens. In 1952, Arvid Carlsson and Nils-Ake

Hillarp established that dopamine acts as a

neurotransmitter in brain. Some of the functions mediated
by dopamine include motor movement, reward, emotion,
cognition, hormone secretion, and renal control

(Dziedzicka-Wasylewska 1994; Gingrich & Caron, 1993).
Dysregulation of the dopaminergic system has been

extensively studied due to its impact on pathological

disorders such as Parkinson's disease, schizophrenia,
Tourette's syndrome, attention deficit hyperactivity

disorder, dopamine dysregulation syndrome, bipolar
disorder, and manic depression (Missale et al., 1998).
Dopamine is also extensively investigated because of its

involvement in the reward mechanisms associated with
cocaine, amphetamine, and methamphetamine addiction (Le
Foil, Gallo, Le Strat, Lu, & Gorwood, 2009; Missale et

al., 1998).
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Dopamine Synthesis

The enzyme tyrosine hydroxylase converts the amino
acid tyrosine to dihydroxyphenylalanine

(DOPA),

which is

then converted into dopamine by the enzyme DOPA
decarboxylase

(Roth,

1979).

Sourkes,

1979;

Smidt,

Smits,

& Burbach,

2003;

Dopamine is also an intermediary step in

the synthesis of norepinephrine and epinephrine.

Tyrosine

hydroxylase is the rate-limiting enzyme in dopamine
synthesis.

Dopamine is synthesized in the presynaptic

terminals of dopaminergic neurons,

and released via calcium-dependent exocytosis

vesicles,

(Binder,

packaged into synaptic

Kinkead,

Owens,

& Nemeroff,

2001).

Dopamine Receptor Structure and Subtypes
The dopamine receptor belongs to a class of receptors
known as seven transmembrane G protein-coupled receptors

(GPCRs)

(Missale et al.,

1998;

Sealfon & Olanow,

2000).

Dopamine receptor subtypes are categorized as being

Dl-like or D2-like

Gingrich & Caron,

1994;

O'Dowd,

(Civelli,

1993;

1993).

differ structurally,

Bunzow,

& Grandy,

1993;

Jackson & Westlind-Danielsson,

These two families of receptors

pharmacologically,

and biochemically.

Included in the Dl-like family are the Di and D5
receptors,

while the D2-like family contains the D2,

and D4 receptors.
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D3,

The DI- and D2-like receptor families differ based on
their ability to stimulate or inhibit adenylyl cyclase
(Dearry,

Kebabian,

1990;

McVittie,

Mahan,

2000;

Gingrich,

Onali,

Trabucchi,

Thambi,
Civelli,

Petzgold,
Gerfen,

Olianas,

1978;

Kushner,
1990).

to G proteins

& Greengard,
Sibley,

& Gessa,

Van Tol,

1985;

Cone,

Bates,

& Caron,

1972; Monsma,

1990; Nicola et al.,

Stoof & Kebabian,

Spano,

1984;

Pribnow,

Govoni,

Zhou,

&

Grandy,

Salon,

Bunzow,

&

Dopamine receptors are typically coupled

(e.g.,

Gs,

others)(Binder et al.,

activated,

Fremeau,

Falardeau,

Goif,

Gi, Go, Gq and possibly

2001). When Dl-like receptors are

the bound G protein

(Gs or Goif)

detaches from

the receptor and stimulates adenylyl cyclase. Adenylyl

cyclase increases cyclic adenosine monophosphate
levels and,

in turn,

activates protein kinase A

When D2-like receptors are stimulated,
protein -(Gi)

is activated,

phosphodiesterase levels.

cAMP,

(cAMP)

(PKA).

an inhibitory G

which increases
Phosphodiesterase breaks down

thus inhibiting PKA and causing an attenuation of

.cellular events and responsiveness

(Missale et al.,

1998).

Distribution of Dopamine Receptors

Dopamine cell bodies are primarily located in the
olfactory bulb,

ventral tegmental area,

substantia nigra pars compacta
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(Snyder,

hypothalamus,

Roberts,

&

and

1991)

SealfOn,

and these cells give rise to four major

pathways: the nigrostriatal,

mesolimbic, mesocortical,

tuberoinfundibular pathways.

Not surprisingly,

and

DI- and

D2--like receptor -mRNA is highly concentrated in the dorsal

striatum.,

nucleus accumbens,

(Sealfon &■ Olanow,

2000).

and olfactory tubercle

The majority of dopamine

.receptors are located postsynaptically,

regions of GABAergic,
cholinergic,

Tarazi,

glutamatergic,

and peptidergic neurons

1996;'Jaber,

Robinson,

at the terminal

serotonergic,
(Baldessarini &

Missale,

& Caron,

1996;

Tarazi & Baldessarini,

19-99;

& Baldessarini, ;1998).

Presynaptic autoreceptors are found

Tarazi,

Campbell,

Yeghiayan,

at the terminal regions of dopamine neurons.

Dopamine receptor subtypes differ according to their
anatomical distribution and relative abundance.

The most

abundant dopamine receptor subtype in the central nervous
system is the Di receptor
Levey,

Niznik,

Sunahara,

1990; Weiner,

(Dearry et al.,
O'Dowd,

Seeman,

& Brann,

1991).

There is no Di mRNA in the entopeduncular nucleus and
substantia nigra pars reticulata
Fremeau et al.,

1991;

Weiner et- al. ,

receptors are expressed

Normand,. & Bloch,

(Dearry et al.,

1991)

(Gerfen et al.,

1990;

even though Di

1990;

Le Moine,

1'991) . These receptors are mainly

present .in projections localized on striatal GABAergic
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neurons co-expressing substance P
Moine et al.,

(Gerfen et al.,

1990;

Le

The GABAergic fibers projecting from

1991).

the striatum to the substantia nigra pars reticulata

represent the direct pathway.

The D5 receptor subtype is far less abundant than the
Di receptor,

with Ds receptor mRNA detectable in the

cerebral cortex,
striatum,

diagonal band,

substantia nigra, medial thalamus,

hippocampus
Morrison,

lateral thalamus,

(Choi, Machida,

& Selfon,

Prikhozhan,

Westlind-Danielsson,

1992;

and

1995;

& Ronnekleiv,

dorsal

Huntley,

Jackson &

1994).

The D2 receptor subtype is present on medium spiny
GABAergic neurons co-expressing enkephalin
Gerfen et al.,

1995; Hersh et al.,

1995; Le Moine et al.,
dorsal striatum,
core

(Bouthenet,

Schwartz,

1991).

Souil,

1992;

1995; Le Moine & Bloch,

and is found mainly in the

olfactory tubercle,
Martres,

and nucleus accumbens

Sokoloff,

Giros,

&

'

■

The medium spiny neurons that extend to

the globus pallidus

indirect pathway.

1990)

(Gerfen,

(striatopallidal neurons)

make up the

D2 receptors are also co-expressed on

neurotensin-containing neurons in the nucleus accumbens
shell

(Diaz,

Sokoloff,

Levesque,

& Schwartz,

Griffon,
1994).

Lammers,

Martres,

To a slightly lesser degree,

D2 receptors have been found in the prefrontal,
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cingulate,

temporal,

and entorhinal cortices,

cells of the hippocampal formation
1’991) .

Interestingly,

as well as the granule
(Bouthenet et al.,

D2 receptors are expressed by

dopaminergic neurons located in the substantia nigra pars

compacta and ventral tegmental area
1991; Meador-Woodruff,
Civelli,

neurons synthesize,

et al.,

Watson,

&

1991). These dopaminergic

and release dopamine at the

store,

somatodendritic level

Bunzom, Van Tol,

Mansour,

Weiner et al.,

1989;

(Bouthenet et al.,

(Bjorklund & Lindvall,

1975;

Bustos

2004).

D3 receptors are expressed by substance P and
neurotensin-containing neurons that project to the ventral

pallidum,

olfactory tubercle,

(Bouthenet et al.,
al.,

1992).

1991;

and islands of Calleja

Diaz et al.,

1994; Levesque et

Few D3 receptors are present in the dorsal

striatum

(Bouthenet et al.,

Martres,

Giros,

Sokoloff,

1992;

Schwartz,

1990),

Souil,

1991; Levesque,

Schott,

Sokoloff,

Morgat,

Giros,

Diaz,

Schwartz,

Martres,

Pilon,

&

Barthenet,

&

while low levels of D3 receptor mRNA are

expressed in dopaminergic neurons located in the
substantia nigra pars compacta and ventral tegmental area

(Diaz et al.,

1994).

In the basal ganglia,

only low numbers of D4

receptors are present in GABAergic neurons of the globus
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pallidus and substantia nigra pars reticulata (Mrzl-jak,

Bergson, Pappy, Huff, Levenson,
The D4 receptor, however,

& Goldman-Rakic, 19'96) .

is found in abundant quantities

in the frontal cortex, amygdala, hippocampus,

hypothalamus, mesencephalon, and retina (Cohen, Todd,
Harmon,

& O'Malley,

1992; Tarazi, Kula,

1992; O'Malley, Harsmon, Tang,
& Baldessarini,

Guan, Sunahara, Seeman, Niznik,

& Todd,

1997; Van Tol, Bunzow,

& Civelli,

1991). In the

hippocampus and cerebral cortex, D4 receptors are located

on both pyramidal and nonpyramidal GABA interneurons and
act to modulate GABAergic transmission (Mrzljak et al.,

1996).
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CHAPTER THREE
DOPAMINE PHARMACOLOGY:

ONTOGENY

Overview

Research on the prenatal and postnatal development of

dopamine receptors has mainly focused oh the dorsal
striatum and nucleus accumbens and has been investigated

using multiple techniques

(i.e.,

in situ hybridization,

binding,

[6-OHDA]

lesions,

autoradiography,

receptor

6-hydroxy-dopamine

irreversible receptor antagonism,

etc.).

Receptor binding and autoradiography use labeled
radioactive ligands to determine the tissue distribution

of dopamine receptors. Because the data are precise and

quantifiable,

receptor binding is preferred when a

specific brain area is of interest. Autoradiography is the
preferred technique when, the goal is to visualize the
distribution of dopamine receptors across brain.

Prenatal Development of the Dopamine System
Dopaminergic cell bodies are first detectable on
embryonic day

(E)

12

(Smidt & Burbach,

2007).

On E 13,

the

axons-begin to extend and by E 14 they are present in the

striatum
Kalsbeek,

14,

(Van den Heuvel & Pasterkamp,
Jorritsma-Byham,

2008; Voorn,

& Groenewegen,

1988). Also on E

dopamine and tyrosine hydroxylase activity can be
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detected .in the striatum (Olson & Seiger,
Picket, Joh,

1972; Specht,

& Reis, 1981). Segregation of ascending axons

is not fully mature until birth (E 21), at which time
projections from the midbrain to the dorsal striatum can

he differentiated from projections to the ventral striatum
(H.u, Cooper, Crockett,

& Zhou, 2004) . During the late

.stages of embryonic development (after E 15), dopaminergic

axons innervate other forebrain structures such as the
prefrontal cortex, hypothalamus, hippocampus,

and amygdala

(van den Heuvel & Pasterkamp, 2008).
Dopamine projections from the substantia nigra pars

cpmpacta to the striatum are evident as early as E 14
1972; Specht et al., 1981). Striatal

.(’Olson & Seiger,

Dl-like binding sites are present in low numbers on E 14,
E 15, and E 16

(Jung & Bennett, 1996). On E 18, as the

striatum is becoming more differentiated, there is a
significant increase in Dl-like binding sites followed by

a decline until birth
Duncan, Breese,

(Jung & Bennett,

Fornaretto, Caron,

1996; Schambra,

& Fremeau,

Striatal D2-like binding sites appear on E 14
Bennett,

1989),

19'96; Sales-, Martes, Bouthenet,

1994).
(Jung &

& Schwartz,

increase dramatically until E 18, and then decline

from E 18 to E 20

(Jung & Bennett, 1996).
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Postnatal Development of the Dopamine System

The dopamine system is not mature at birth and
continues to develop across ontogeny.

Findings regarding

the postnatal development of Dl-like receptors have been

inconsistent. A linear increase in Dl-like receptors has
been reported from birth
adulthood

& Joyce,

& Murrin,

Hyttel,

Robertson,

(Leslie,

Rao, Molinoff,

(postnatal day 0;

Cutler,

& Bennett,

Schambra et al.,

1991;

1988). Alternately,

into

PD 0)

1991;

1994;

Zeng,

there are reports of

a gradual increase in striatal Dl-like receptors until

followed by a decline in receptor

approximately PD 35-40,

(pruning)

numbers

adulthood

to a level that is sustained into

(Gelbard,

Giorgi,

DeMontis,

Biggio,

1987).

Teicher,

Porceddu,

Regardless,

Faedda,
Mele,

& Baldessarini,

Calderini,

1989;

Toffano,

&

researchers agree that receptor

stimulation during a critical postnatal period is

necessary for the normal development of Dl-like receptors
(Kostrzewa & Saleh,

Saleh & Kostrzewa,
1998).

1989;

Neal-Beliveau & Joyce,

1988; Thomas,

Not surprisingly,

Neal-Beliveau,

1992;
& Joyce,

the normal development of Dl-like

receptors is dependent on the presence of endogenous

dopamine
Marsh,

(Gelbard,

Zorc,

Teicher,

& Faedda,

Baldessarini,

1990; Neal & Joyce,
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Gallitano,
1992).

Research on the postnatal development of D2-like

receptors has also yielded inconsistent findings.

Some

studies describe a progressive increase in D2-like binding

sites that reach adult-like levels approximately two weeks
after birth

Pardo,

1983; Murrin & Zeng,

(Hartley & Seeman,

Creese,

Burt,

Schambra et al.,

1977; Rao et al.,

& Snyder,

1994).

1986;

1991;

D2-like binding sites have also

been reported to increase linearly from birth until PD 40,
followed by a decline
al.,

(pruning)

1989; Teicher, Anderson,

to Dl-like receptors,

into adulthood

& Hostetter,

1995).

1989;

Similar

normal development of D2-like

receptors is dependent on receptor stimulation
& Saleh,

(Gelbard et

Neal-Beliveau & Joyce,

(Kostrzewa

1992); however,

the

availability of endogenous dopamine is not important for

D2-like receptor development
Bondy,

& Mueller,

Iorio,

(Breese,

Duncan,

Napier,

1987; Neal-Beliveau & Joyce,

1992).

At birth,
adult levels

Dl-like receptor mRNA levels are 75% of

(Schambra et al.,

1994).

Regardless of these

high mRNA levels,

[3H]SCH23390 binding is very low

(Schambra et al.,

1994).

The density of Dl-like binding

sites increases until PD 14 to PD 21,

relatively stable throughout adulthood

1994). At birth,

where it remains
(Schambra et al.,

D2-like receptor mRNA levels are also
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high, but as observed for Dl-like receptors,

D2-like

receptor binding sites are low. Maximum levels of D2-like
binding sites are not observed until PD 30
al.,

(Schambra et

1994) .

Ontogeny of Dopamine Systems
Across ontogeny,

functional changes.

dopamine systems undergo numerous

For example,

there are age-dependent

alterations in dopamine levels and the functioning of
release-modulating autoreceptors,

there are changes in

receptor-mediated adenylyl cyclase activity,

and both

quantitative and qualitative alterations in drug-induced

behaviors.

In the first case,

striatal dopamine levels

increase linearly from birth until approximately PD 35,
when adult levels are reached

1990).

(Walters,

Chapman,

& Howard,

In terms of release-modulating autoreceptors,

SKF38393

(a selective Dl-like agonist)

evokes

significantly less dopamine release in the striatum of
preweanling rats than adults,

with adult-like functioning

not occurring until approximately PD 35

1990).

(Walters & Howard,

Indirect dopamine agonists also differentially

affect release depending on age,

because a low dose of'

amphetamine increases dopamine release in adult rats,
while preweanling rats show an initial increase in

dopamine release followed by a persistent decline
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(Gazzara,

Fisher,

& Howard,

1986). Also,

methamphetamine

causes less dopamine release on PD 14 than PD 21

Sakai,

(Tsuchida, Akiyama,

Ujike,

Li,

1996).

& Kuroda,

Research shows that synthesis-modulating dopamine

autoreceptors are functional during the preweanling period
(Andersen,

Charntikov,

Dumont,

1997;

& Teicher,

& McDougall,

Crawford,

Varela,

Der-Ghazarian,

2010),

with

adult-like functioning being achieved by approximately PD

40

(Anderson,

Booth,

2003;

Baldessarini,

& Owens,

Marsh,

1994).

Dopamine receptors,

as mentioned earlier,

belong to a

class of G protein coupled receptors that either activate

or inhibit adenylyl cyclase.

Specifically,

Dl-like

receptor stimulation increases adenylyl cyclase activity,
while D2-like receptor stimulation inhibits adenylyl

cyclase.

When considering striatal structures,

Dl-like

receptors are functional and coupled to adenylyl cyclase
by E 17

(De Vries,

Mulder,

& Schoffelmeer,

Dl

1992).

mediated adenylyl cyclase activity increases from E 20 to

PD 21,

at which time activity declines until adult levels

are reached at PD 35

(Sakagami,

Sawamura,

& Kondo,

1995).

The functional development of D2-like receptors is much
slower,

as evidenced by the inability of D2-like receptors

to inhibit adenylyl cyclase activity until PD 14
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(De Vries

et al,,

1992). D2-like mediated adenylyl cyclase activity

does not reach adult levels until PD 21

(De Vries et al.,

1992).
Dopamine system functioning at the pre- and

post-synaptic levels can also be assessed by examining
drug-induced changes in behavior. Interestingly,
stimulating postsynaptic dopamine receptors can induce
different behavioral effects in preweanling and adult

rats. For example, the D3 agonist

(+)-PD128,907 increases

locomotor activity in 14-day-old rat pups, while
attenuating locomotion in adult rats
Fuxe, 2000),

(Heijtz, Ogren,

&

(4-)-PD128,907 does not induce adult-like

behaviors until PD 21, thus indicating that the D3
receptor is. not functionally mature until the second to

third postnatal week (Heijtz et al., 2000). Also,
administering the nonselective dopamine agonist

R-propylnorapomorphine (NPA)

into the dorsal striatum of

adult animals causes minimal locomotion (Bordi, Carr,

Meller,

&

198.9; Bordi & Meller, 1989) ; whereas, NPA produces

robust locomotor activity in preweanling rats

Halladay, Herbert, Marquez,

(Charntikov,

& McDougall, 2008). This

finding suggests that adult-like responsiveness to NPA is

not observed until after the preweanling period.

Similarly, the Dl-like agonist SKF38393 induces grooming
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and sniffing throughout the preweanling period
& Nonneman,

Arnold,

1990;

Moody & Spear,

(McDougall,

1992),

even

though SKF38393 does not produce adult-like stereotyped

responding until approximately PD 21

(Moody & Spear,

1992).

The ontogeny of presynaptic dopamine receptors has
also been investigated by assessing drug-induced behavior.

Administering a low dose of a direct dopamine agonist

(e.g.,

decreases the locomotor activity of

quinpirole)

adult rats

(Eilam & Szechtman,

Dall'Olio,

& Gandolfi,

1989; Montanaro,

presumably by stimulating

1983),

release- and synthesis-modulating autoreceptors
review,

see Starke,

contrast,

& Kilbinger,

low doses of quinpirole

dopamine agonist),
agonist),

Gothert,

and

(+)

apomorphine

1989).

(for a
In

(a selective D2/D3

(a non-selective dopamine

([3-(3-hydroxyphenyl)-

3-PPP

N-n-propylpiperidine};

Vaccheri,

a dopamine partial agonist)

increase the locomotor activity of preweanling rats

1983; Camp & Rudy,
Sourkes,

Nonneman,
1980;

Kellogg & Lundborg,

1973; McDougall et al.,
1989;

Sobrian,

animals,

1987;

Moody & Spear,

Jones,

Varghese,

1972;

(Arnt,
Lal &

1990; McDougall &

1992;

Shalaby & Spear,

& Holson,

the ability of apomorphine,

(+)

2003).

3-PPP,

In young
and

quinpirole to suppress locomotion is not apparent until
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approximately PD 28 or PD 30

Lundborg,

Meyer,

(Arnt,

1983; Hedner &

1985; Shalaby & Spear, 1980; Van Hartesveldt,

& Potter,

1994). The latter finding suggests that

dopamine autoreceptors are not functionally mature until

after the preweanling period.
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CHAPTER FOUR
ADULT DOPAMINE-MEDIATED BEHAVIOR

Introduction

Dopamine agonists and antagonists have been used to

elucidate the role played by certain basal ganglia
the dorsal striatum and nucleus

structures

(e.g.,

accumbens)

in mediating the locomotor activity and

stereotyped behaviors of animals. Administration of such
compounds is achieved by systemic injections or precisely

targeted intracranial infusions. Techniques such as brain
lesioning and irreversible dopamine receptor antagonism

have also been employed to determine the involvement of

basal ganglia structures in motoric function.

Early

behavioral and anatomical studies indicated that the
dorsal striatum was important for the expression of

while the nucleus accumbens was

stereotyped behaviors,

important for mediating locomotion

Carr & White,
Kelley,

Lang,

Kostowski,

1984;

Delfs,

& Gauthier,

1989).

(Bordi et al.,

Schreiber,

1988;

& Kelley,

Plaznik,

1989;

1990;

Stefanski,

&

Further research has shown that there is

less behavioral specificity to these structures than
originally reported

Brunhara,
Carrera,

(Canales & Iversen,

Schwarting,
2006;

& Tomaz,

Dickson,

Lang,
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1998;
Hinton,

1998;

Dias,

Carrera,

Carey,

& Kelley,

&

1994;

Prinssen,

Koene,

& Cools,

& Khroyan,

O'Dell,

1993; Neisewander,

Fuchs,

1998).

Systemic Administration of Dopamine
Receptor Agonists

Selective Dl- and D2-like receptor agonists

differentially affect the unlearned behaviors of adult
rats.

Selective D2-like agonists,

RU24213,

cause an increase in locomotor activity,

sniffing,

1987).

such as quinpirole and

yawning,

In contrast,

and rearing

(Arnt,

1987; Clark & White,

systemically administering the Dl-like

partial agonist SKF38393 or the Dl-like full agonist
LU24-040 does not'cause locomotion but preferentially

although low levels of

increases grooming behavior;

locomotion are sometimes observed after SKF38393

1985,

1987;

Montanaro,
Waddington,

Serra,

Dall'Olio,
1988;

Gandolfi, Vaccheri,

Molloy & Waddington,

1989; Neisewander,

Collu,

& Gessa,

1987;

Lucki,

(Arnt,

Roncada,

&

1984; Murray &
& McGonigle,

Starr & Starr,

1991;

1987) .

Interestingly, monoamine depleted and 6-OHDA-treated rats
show increased locomotor activity when challenged with

SKF38393

(Arnt,

Mueller,

1985;

1985;

Breese,

Breese et al.,

1991).
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Baumeister,
1987;

Napier,

Frye,

Neisewander et al..,

&

Systemic administration of selective D2-like receptor

agonists

(i.e.,

quinpirole Or pergolide)

affects the

locomotor activity of adult rats in a biphasic manner

(Bradbury,

Cannon,

1981;

& Naylor,

Hartesveldt,

Costall,

& Naylor,

Eilam & Szechtman,

1995;

1984;

1989;

Koller & Herbster,

Costall,

Lim,

Frantz & Van

Specifically,

1988).

low doses of quinpirole attenuate locomotor activity,
while high doses augment locomotion

1989;
al.,

Frantz & Van Hartesveldt,

1994).

(Eilam & Szechtman,

1995; Van Hartesveldt et

The biphasic behavioral effects of quinpirole

are explained by its relative affinity for pre- and

postsynaptic D2-like receptors.

Specifically,

quinpirole

has a higher affinity for presynaptic D2-like receptors
than for postsynaptic receptors

Van Hartesveldt,
Therefore,

Cottrell,

(Eilam & Szechtman,

Potter,

1989;

1992).

& Meyer,

when administered at high doses,

quinpirole

stimulates postsynaptic receptors and locomotion is
increased. When administered at low doses,

quinpirole

preferentially stimulates presynaptic receptors thereby

decreasing dopamine levels and locomotion.
quinpirole induce mild stereotypies,

rearing,

High doses of

such as sniffing and

even though selective D2-like agonists typically

do not produce intense stereotyped behaviors
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(Arnt,

1987;

& Perregaard,

Hyttel,

1985; Meller,

Bordi,

Christensen, Arnt,

& Bohmaker,

& Svendsen,

1988).

A full range of stereotyped behaviors are also

observed when selective Dl- and D2-like agonists are
coradministered

Braun & Chase,

1987;

(Arnt,

1986).

When

the selective Dl- and D2-like

given in combination,

agonists SKF38393 and quinpirole elicit a dose-dependent
increase in locomotor activity,
after a unilateral lesion,

as well as stereotypies like

repetitive grooming and sniffing

Clark & White,

& Shohmori,

1987;

1996).

contralateral circling

Kashihara,

(Braun & Chase,

Akiyama,

1986;

Ishihara,

Shiro,

Co-administration of quinpirole with

either the Dl-like agonist SKF75670 or LU24-040 causes a

dose-dependent increase in licking and occasional biting
behavior

•

(Arnt et al.,

1987).

Systemic Administration of Nonselective
Dopamine Agonists

•

Nonselective dopamine agonists stimulate both Dl- and

D2-like receptors. Not surprisingly,

co-stimulation of Dl-

and D2-like receptors induces a pattern of behavior that
is similar to,

but more intense than,

after D2-like agonist administration

1984; Ljungberg,
3-PPP,

1986). At low doses,

like quinpirole,

what is observed
(Bradbury et al.,
apomorphine or

(+)

increases the locomotor activity
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of adult animals

(Bradbury et al.,

1981). At high doses,

1984;

Costall et al.,

nonselective dopamine receptor

agonists induce more intense behavioral responses.

adult rats receiving a high dose of apomorphine

example,

exhibit intense stereotyped behaviors,

gnawing,

rearing,

and licking

biting,

1973; Lepekhina & Tsitsurina,
Schi0rring,
Golani,

For

1971;

1985).

Szechtman,

2007;

such as sniffing,
(Costall & Naylor,

Ljungberg,

Ornstein,

1986;

Teitelbaum,

&

Systemic treatment with either a selective

DI- or D2-like receptor antagonist attenuates these
stereotyped behaviors

(Arnt,

1987;

Braun & Chase,

1986).

Intracranial Microinjection of Dopamine
Agonists in the Dorsal Striatum

Early studies investigating the neural substrates of

unlearned motor behavior indicated that the dorsal
striatum is necessary for the expression of stereotyped
behaviors

Canales,

(Allen & Winn,
Gilmour,

Kelley et al.,

Stellar,

2002).

1995;

& Iversen,

Bordi et al.,

2000;

1989;

Carr & White 1984;

1988; Waszczak, Martin,

Finlay,

Zahr,

Infusing quinpirole into the dorsal

striatum results in moderate stereotyped behaviors,

as head-down sniffing and licking
1988;

&

Delfs & Kelley,

1990).

such as biting or gnawing,

such

(Canales & Iversen,

Intense oral stereotypies,

are not observed when
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quinpirole is administered alone.
SKF38393

Conversely,

infusing

into the dorsal

(a partial Dl-like agonist)

striatum does not elicit stereotyped behaviors; whereas

SKF82958

stereotypy

2004;

infusions produce mild

(a full. Dl-like agonist)
(Gower & Marriott,

Krolewski,

Bishop,

1982; Kreipke & Walker,

& Walker,

2005).

Co-stimulation of Dl- and D2-like receptors in the
dorsal striatum causes more intense behaviors to be

expressed. At low doses,

the nonselective agonists

apomorphine and NPA cause both locomotion and rearing

(Bordi et al.
1998;

1989;

Dias et al.,

Dickson et al.,

2006); whereas,

1994; Carrera et al.,
infusing higher doses

of apomorphine or a "cocktail" of SKF38393 and quinpirole
produces robust stereotypy

Kelley,
2002).

1990;

(Bordi & Meller,

Gower & Marriott,

Similarly,

Delfs &

1989;

1982; Waszczak et al.,

microinjecting dopamine or NPA into the

dorsal striatum causes minimal locomotor activity,-but

moderately intense oral and sniffing stereotypies as well

as chewing and gnawing

(Bordi et al.,

Marsden, Naylor,

& Pycock,

Dahlstrom,

Pijnenburg,

Rossum,

1975;

1976).

1976;

1989;

Costall,

Jackson,.Anden,

Honig,

&

Van der Heyden,

& Van

This robust stereotypy is similar to what

is observed when indirect dopamine agonists,
amphetamine or cocaine,

such as

are infused into the dorsal
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striatum

1984; Waszczak et al.,

(Staton & Solomon,

Therefore,

2002).

concurrent DI- and D2-like receptor stimulation

is necessary for the expression of intense stereotyped
behaviors in adult rats

(Waszczak et al.,

2002).

Intracranial Microinjection of Dopamine
Agonists in the Nucleus Accumbens

Research has shown that the nucleus accumbens is at

least partially responsible for mediating the locomotor

activity of adult rats

al.,

1990;

Redmond,
Huston,

(Canales & Iversen,

1997; Neisewander,

Hauber & Miinkle,

1995;

Plaznik,

& Schwarting,

2000;

et al.,

1998).

1989;

Delfs et

O'Dell,

&

Schildein, Agmo,

Specifically, microinjecting

the Dl-like agonists SKF38393 or SKF82598 into the nucleus

accumbens induces moderate locomotor activity in adult

rats

(Meyer,

Swanson,

1993;

Meyer,

Stratford,

Heath,

Van Hartesveldt,
& Kelley,

& Potter,

1993;

1997). Also,

intraaccumbal infusions of the D2/D3 receptor agonist

quinpirole causes a modest increase in locomotion
& Jackson,

1989;

Gong,

Hartesveldt et al.,
Mogenson & Wu,

Lynn,

Neill,

& Justice,

(Dreher

1999; Van

1992; but see Canales & Iversen,

1991).

2000;

Bilateral co-administration of Dl-

and D2-like receptor agonists into the nucleus accumbens
also produces a dose-dependent increase in locomotor

activity

(Canales & Iversen,

1998;
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Colle & Wise,

1991;

Dreher & Jackson,
Seyiour,

1989;

1989;

& Iversen,

Dopamine agonists,

Ikemoto,
Messier,

2002;

Kelly,

& Destrade,

1984).
when given in combination or

cause other classes of behavior to be expressed as
For example,

well.

1972;

1975; Mrabet,

Staton & Solomon,

alone,

Fog,

selective Dl-like agonists

increase wall climbing in addition

SKF38393 and CY208243)
to locomotor activity

(i.e.,

(Dreher & Jackson,

1989). More

orofacial stereotypies and head-down sniffing

importantly,

are evident when cocaine or quinpirole is microinjected
into the nucleus accumbens of adult rats
Iversen,

1998).

1998;

Koene et al.,

(Canales &

1993; Neisewander et al.,

targeted injections into the nucleus

Thus,

accumbens that .stimulate Dl-like receptors,

receptors,

D2-like

or both receptor types increases locomotor

activity as well as some stereotypies.

Synergistic Interaction between Dland D2-Like Receptors
Overall,

Dl-like receptor stimulation in the dorsal

striatum causes mild stereotypies,

whereas D2-like

receptor stimulation causes moderately intense

stereotypied behaviors.

High intensity stereotyped

behaviors are only evident when both DI- and D2-like

receptors are co-stimulated

(Arnt,

40

1987;

Braun & Chase,

1986).

When considered together,

these results suggest

that both the Dl- and D2-like receptor systems must be
functional for the full expression of certain

dopamine-mediated behaviors
stereotypies).

Moreover,

0'Boyle,

SCH23390

(a

attenuates D2-like

agonist-induced behaviors

Pugh,

high-intensity

Consistent with this idea,

selective DI antagonist)

1985;

(i.e.,

(Arnt,

1985;

Breese & Mueller,

& Waddington,

Molloy,

1985).

the behavioral effects produced by

co-administering DI- and D2-like agonists can be

attenuated by either a DI- or D2-like receptor antagonist
(Arnt,

1987;

Dreher & Jackson,

1989).

Taken together,

this

evidence is consistent with the hypothesis that the DI

receptor system provides the necessary tonic background
activation required for the full manifestation of D2-like

(Murray & Waddington,

receptor-mediated behaviors

1989).

• Summary

the dorsal striatum is

In adult rats and mice,

largely responsible for mediating the stereotypy-inducing
effects of dopamine agonists,

while the nucleus accumbens

is important for modulating locomotor activity.

dichotomy is not absolute,

This

however, because infusing Di

or D2-like agonists into the nucleus accumbens produces

some stereotypy.

Conversely,

infusing apomorphine,
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NPA,

or

amphetamine into the dorsal striatum induces locomotor
activity as well as stereotypy.

In sum,

the function of

the dorsal striatum and nucleus accumbens is not mutually
exclusive; multiple neural networks in the basal ganglia
are responsible for the behavioral responses induced by

dopamine receptor agonists.
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CHAPTER FIVE
ONTOGENY OF DOPAMINE-MEDIATED BEHAVIOR

Introduction

The ontogeny of basal ganglia motor systems has not
been thoroughly investigated,

although dopamine-mediated

behaviors often show maturational changes across
development

(Broaddus & Bennett,

1985; Lin & Walters,

Hedner & Lundborg,

1990;

1994). As eveidence of this fact,

the

behavioral responses elicited by dopaminergic compounds
can vary both qualitatively and quantitatively across

ontogeny.

Systemic Administration of Selective and
Nonselective Dopamine Agonists
From an early age,

dopamine systems are responsive to

direct and indirect dopamine agonists
Spear,

1979).

In some cases,

(for a review,

see

dopamine agonists affect the

behaviors of young and‘adult rats in a similar manner.

example,

For

a high dose of apomorphine induces forward

crawling and stereotyped tongue protrusions as early as PD
2

(Kellogg & Lundborg,

1972)

and causes adult-typical

increases in locomotor activity by PD 7

1980).

Similarly,

(Shalaby & Spear,

administering the indirect dopamine

agonist amphetamine on PD 2 causes an initial period of
locomotion

(lasting 1-2 hr),

followed by a phase of tongue
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protrusions

sniffing,

(Lal & Sourkes,

locomotion,

1973). Amphetamine-induced

grooming,

observable from PD 12 to PD 16,

and licking is clearly
and becomes more

continuous and adult-like from PD 18 to PD 30

Sourkes,

1973).

By PD 35,

(Lal &

these behaviors are

indistinguishable from those of adults.

Consistent with

the latter studies, McDougall and colleagues have shown

that systemically administered NPA,

cocaine,

and

amphetamine increases both locomotor activity and

head-down sniffing on PD 17

McDougall,

(McDougall & Bolanos,

Crawford, Nonneman,

1995;

1993; McDougall,

Rodarte-Freeman,

& Nazarian 1999; Nazarian,

Rodarte-Freeman,

& McDougall 1999).

Consistent with these results using nonselective

dopamine agonists,

young and adult rats show similar

behavioral responses when treated with selective DI- and

D2-like agonists.

Specifically,

high doses of the Dl-like

partial agonist SKF38393 elicits adult-typical grooming on

PD 10
1992),

(McDougall, Arnold,

1990; Moody & Spear,

as well as head-down sniffing throughout the

preweanling period

1992;

& Nonneman,

(Byrnes & Bruno,

Sobrian et al.-,

2003).

1994'; Moody & Spear, ■

The D2-like agonist

quinpirole produces forward locomotion and stereotyped

behaviors,

such as licking,

sniffing,
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and mouthing,

from

at least PD 3 through PD 22
McDougall et al.,

al.,

1990,

(Brynes & Bruno,

Moody & Spear,

2003; Van Hartesveldt et al.,

however,

1992;

1994).

1994;
Sobrian et

There are,

some minor discrepancies in the literature

because Moody and Spear

(1992)

reported that quinpirole

decreases the incidence of grooming and licking on PD 21,
although they did observe increased vertical movements.

Quinpirole causes a biphasic locomotor response in both

young and adult rats,

with high doses attenuating

locomotion and low doses augmenting locomotion
Spear,

1992; Van Hartesveldt et al.,

(Moody &

1994).

Co-administration of DI- and D2-like agonists on PD 10
causes an increase in forward locomotion,

sniffing,

and vertical movements

Interestingly,

circling,

(Moody & Spear,

1992).

co-stimulation of DI- and D2-like receptors

does not induce adult-typical stereotyped licking and
biting until PD 21

(Moody & Spear,

1992).

Although dopaminergic drugs typically produce similar
effects in young and adult rats,

some qualitative and

quantitative age-dependent differences have occasionally

been observed
Spear,

1980;

example,

(for reviews,
Spear,

1979;

see Andersen,

Spear & Brake,

2003;

1983).

Shalaby &

For

apomorphine-induced stereotyped sniffing is not

evident in-animals younger than PD 21

45

(Shalaby & Spear,

and a low dose of apomorphine is unable to suppress

1980)

locomotor activity until after PD 35

1980).

In a similar vein,

(Shalaby & Spear,

greater doses of SKF38393 are

needed to evoke a grooming response on PD 10 than at older

(McDougall et al.,

ages

Conversely,

1990;

1992).

Moody & Spear,

SKF38393 elicits a more pronounced locomotor

response in preweanling rats than adults

1994; McDevitt & Setler,
Moody & Spear,

1992;

(Byrnes & Bruno,

1981; McDougall et al.,

Shieh & Walters,

1990;

1996).

Intracranial Microinjection of Selective and
Nonselective Dopamine Agonists

Only a few microinjection experiments have been

conducted during early ontogeny. Nonetheless,

available

research shows that dopamine agonists differentially
affect the behavior of preweanling and adult rats.

18,

On PD

microinjecting NPA into the dorsal striatum causes a

biphasic increase in locomotor activity

al.,

2008).

Specifically,

(Charntikov et

a low dose of NPA

dramatically increases forward locomotion,

doses

(10 or 20 ug)

assessed,

whereas higher

have a lesser effect. Although not

it is likely that 10 and 20 ug NPA

preferentially induced stereotypy,
activity.

(5 ug)

rather than locomotor

Consistent with this interpretation,

infusing

moderate doses of NPA or a "cocktail" of SKF82958 and
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quinpirole into the dorsal striatum,

enhances both

locomotor activity and stereotypy in young rats
(Charntikov,

Gutierrez,

Der-Ghazarian,

Varela,

Herbert,

& McDougall,

Horn,

2011).

Widarma,

In contrast,

infusing NPA into the same brain region of adult rats

causes minimal locomotor activity and intense oral and
sniffing stereotypies

(Bordi,

Carr,

1989).

& Meller,

Ontogenetic behavioral differences are also observed

after selective stimulation of DI- and D2-like receptors

in the dorsal striatum.

In terms of preweanling rats,

bilaterally infusing a low dose of SKF82958

(3 ug)

into

the dorsal striatum preferentially increases locomotor

activity,

while a high dose of SKF82958

stereotypies,

(10 ug)

increases

such as repetitive motor movements,

head-down sniffing,

and behavioral intensity scores

(Charntikov et al.,

2011).

Infusing quinpirole into the

dorsal striatum also induces both locomotor activity and

stereotypy on PD 18

specifically,

(Charntikov et al.,

a low dose of quinpirole

greater locomotion than higher doses

2011).

(10 ug)

More

stimulates

(20 or 30 ug),

whereas high doses of quinpirole induces more stereotypy

than lower doses

(Charntikov et al.,

2011).

In comparison,

adult rats only exhibit mild stereotypies when a Dl
agonist is infused into the dorsal striatum
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(Kreipke &

Walker,

2004; Krolewski et al.,

2005),

whereas a more

intense stereotypic response results from D2 receptor
stimulation

1990).

(Delfs & Kelley,

Ontogeny of Dl- and D2-Like Receptor Synergism

Ontogenetic studies have consistently shown that
coupling between Dl- and D2-like receptors is evident from
a young age.

For example,

co-administration of Dl- and

D2-like agonists elicits synergistic increases in vertical

rolling,

movements,

and curling at PD 3;

locomotion by PD 10;

PD 21

(Moody & Spear,

enhanced forward

and adult-like stereotyped licking at
1992).

Consistent with a D1/D2 synergism hypothesis,

the

Dl-like antagonist SCH23390 attenuates quinpirole-induced
locomotor activity in both adult and preweanling

and PD 17)

rats

(Arnt et al.,

1988; McDougall et al.,
studies,

1990).

1987;

(PD 11

Dall'Olio et al.,

In terms of microinjection

infusing SCH23390 into the dorsal striatum

•

partially attenuates quinpirole-induced locomotor activity
on PD 18,

thus indicating that tonic Dl-like receptor

activation is necessary for the full expression of
D2-mediated behaviors

Conversely,

(Charntikov et al.,

2011).

infusing the D2-like antagonist raclopride

into the dorsal striatum completely attenuates
SKF82958-induced locomotor activity on PD 18.
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Taken

together,

these data indicate that the DI- and D2-like

receptors systems are functionally coupled in an

adult-like manner during the neonatal and preweanling
periods.
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CHAPTER SIX

IRREVERSIBLE DOPAMINE RECEPTOR ALKYLATION

Overview

N-ethoxycarbonyl-2-ethoxy-l,2-dihydroquinoline

(EEDQ)

is an alkylating agent that non-competitively binds to and

including DI- and D2-like

inactivates various receptors,

dopamine receptors,

(Adler,

and GABA receptors
& Hyttel,

1988;

Greenblatt,

Meller,

Hamblin & Creese,

& Friedhoff,

Goldstein,

Sailer,

as well as a-adrenergic,

& Shader,

Kreamer,

1985;

neuron as a whole

Lumpkin,

& Salama,

1994a,

Galpern,

& Hyttel,

1989) .

Importantly,

1983; Crawford,

1994b; Giorgi & Biggio,

To increase receptor specificity,

1988;

without damaging the

(Hamblin & Creese,

& Bardo,

McDougall,

Bohmaker,

1983; Meller,

Miller,

EEDQ inactivates only receptors,

1985; Arnt

& Goldstein,

1991; Nowak, Arnt,

Adamovage,

serotonin,

1990a).

antagonist pretreatment

can be used to selectively protect the receptor of

interest.

Because of these properties,

EEDQ is a useful

tool for investigating neural pathways and age-dependent
differences in dopamine receptor turnover and recovery
(Battaglia et al.,

Fuxe, Agnati,
Gariano,

al.,

Merlo Pich,

& Creese,

1988).

1988;

Crawford et al,

Meller,

1994a,

& Goldstein,

1984; McDougall et al.,

1994b;

1987;

1993;

Leff,

Nowak et

Irreversible dopamine receptor antagonism has
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also been used to study behavior.

EEDQ is useful because

it allows the effects of dopamine receptor blockade to be
assessed without using acute treatment with reversible

antagonists

Crawford,

Hyttel,

(Arnt,

& Nonneman,

1988; McDougall,

& Meier,

1992; McDougall et al.,

1993).

Behavioral Effects of EEDQ in Adult Animals

In adult rats,

EEDQ has been administered both

systemically and intracranially. When EEDQ is administered

it causes catalepsy and attenuates

systemically,

amphetamine-induced stereotypy and locomotor activity

(Belleau,

Martel,

Lacasse,

1986; Hamblin & Creese,
Roth,

1987).

Menard,

Weinberg,

1983; Henry,

Joseph,

& Perron,

Kochman,

&

EEDQ treatment also disrupts the ability of

direct dopamine agonists to increase locomotor activity

and decrease grooming
example,

(McDougall et al.,

For

adult animals treated with EEDQ show decreased

levels of apomorphine-,

quinpirole- and NPA-induced

sniffing and oral stereotypies,

presumably because of

reductions in DI- and D2-like receptors

1988; Arnt & Hyttel,
Crocker,

1992).

1989;

1993; Meller,

1989;

Bordi et al.,

Hamblin & Creese,

Hizami,

& Kreuter,

(Arnt et al.,
1989;

Cameron &

1983; Keller & Molina,
1989).

This attenuated

behavioral response persists for 4-8 days,

after which

normal responsiveness to NPA and other agonists resumes.
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The functional properties of dopamine receptors have
also been studied after intracranial EEDQ administration.

Bilateral infusions of EEDQ

into the

(0.5-1.5 ug/side)

dorsal striatum causes a significant decrease in

(Neisewander,

SKF38393-induced grooming and oral movements

Ong,

& McGonigle,

1995). Attenuation of these

SKF38393-induced stereotypies does not occur if the

Dl-like antagonist SCH23390 is administered

EEDQ infusions.

In other words,

(IP)

prior to

pretreating rats with

SCH23390 selectively protects Dl-like receptors from the

alkylating effects of EEDQ.

This pattern of results

suggests that SKF38393-induced grooming and oral behaviors

are partially mediated by the Dl-like receptor
(Neisewander et al.,

1995).

Consistent with the previous results,

infusing EEDQ

unilaterally into the dorsal striatum diminishes
NPA-induced behaviors such as sniffing,

biting

(Bordi et al.,

licking,

and

1989). Apomorphine-induced head-down

sniffing was also attenuated after bilateral infusions of
EEDQ into the anterior/dorsal portion of the dorsal
striatum,
Crocker,

but not the dorsal/posterior portion

1989).

(Cameron &

In terms of selective D2-like agonists,

systemic administration of quinpirole produces ipsilateral

circling in adult rats given unilateral EEDQ infusions
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into the dorsal striatum

(Giorgi & Biggio,

1990b).

The

latter effect is mediated exclusively by D2-like

receptors,

because quinpirole-induced circling was only

evident when D2-like receptors, but not Dl-like receptors,
were inactivated on a given side

More specifically,

(Giorgi & Biggio,

1990a).

quinpirole-induced circling was not

apparent if D2-like receptors were protected from EEDQ;

whereas,

protecting Dl-like receptors did not impact

circling

(Giorgi & Biggio,

1990a).

Behavioral Effects of EEDQ in
Preweanling Animals

EEDQ produces dramatically different behavioral
effects during the preweanling period.
observed in adult rats,

Unlike what is

NPA-induced locomotor activity is

not blocked by EEDQ administration on PD 11 or PD 17
(McDougall et al.,

1992).

Likewise,

EEDQ does not

attenuate NPA-induced reductions in grooming behavior
(McDougall et al.,

1992).

not unique to NPA,

because the SKF38393- and

These paradoxical effects are

quinpirole-induced behaviors of preweanling rats are also
not attenuated by EEDQ

Mestlin & McDougall,

(McDougall et al.,

1993).

Specifically,

1992,

1993;

preweanling rats

continue to exhibit normal NPA- and quinpirole-induced
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locomotor activity and SKF38393-induced grooming after

EEDQ pretreatment.
Interestingly,

EEDQ does block amphetamine-induced

locomotor activity in both preweanling and adult rats
(Crawford et al.,

1994b).

In preweanling rats,

this

amphetamine-induced effect is not dopamine mediated,

because behavior was not preserved if Dl- and D2-like

receptors were protected with SCH23390 and sulpiride.
contrast,

In

amphetamine-induced increases in locomotion were

still evident in EEDQ-treated adult rats that had been

pretreated with SCH23390 and sulpiride

1994b).

Thus,

(Crawford et al.,

EEDQ depresses amphetamine-induced behaviors

in both age groups,

but only in adult rats is this effect

mediated by dopamine receptors. When these results are
considered together,

it appears that EEDQ produces

qualitatively different behavioral effects in preweanling
and adult rats.

In preweanling animals,

EEDQ does not

attenuate behaviors stimulated by direct Dl- and D2-like

agonists, whereas EEDQ blocks SKF38393- and

quinpirole-induced behaviors in adult rats.
As just mentioned,

various studies have examined the

effects of systemically administering EEDQ during the
preweanling period,

however only a single experiment has

assessed the behavioral impact of microinjecting EEDQ into
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specific brain regions of the preweanling rat.
study,

Charntikov et al.

(100 pg)

(2011)

In that

bilaterally infused EEDQ

into the dorsal striatum of PD 17 rats and then

measured NPA-induced behaviors 24 hr later

18). Unexpectedly,

(i.e.,

on PD

EEDQ-pretreated rats showed a

potentiated locomotor response when 5,

was infused.into the dorsal striatum.

10, .or 20 pg NPA

This result differs

importantly from earlier ontogenetic work,

because

systemically administered EEDQ was reported to leave the
dopamine-mediated behaviors of preweanling rats unaffected
(Crawford et al.,

1994b; McDougall et al.,

Mestlin & McDougall,

1993).

In contrast,

1992,

1993;

microinjecting

EEDQ into the dorsal striatum produced receptor changes
that permitted an exaggerated behavioral response after

NPA treatment

(Charntikov et al.,

2011).

It is unknown

whether NPA's behavioral effects are caused by

EEDQ-induced changes in dopamine receptors 'or- some other

receptor type.

Neurochemical Effects of EEDQ in Adult and
Preweanling Animals
In adult animals,

systemic administration studies

have shown that EEDQ inactivates a substantial proportion

of dopamine receptors.
7.5,

15,

On PD 90,

systemic treatment with

or 25 mg/kg EEDQ reduced dorsal striatal Dl-like
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binding sites by 86%,

86%,

sites were reduced'by 80%,

(Crawford,

McDougall,

6 mg/kg EEDQ

(IP)

and 93%,

82%,

Rowlett,

while D2-like binding

and 92%,
& Bardo,

respectively

reduced Dl- and D2-like binding sites in

the dorsal striatum of adult rats by 70%-82%

al.,

Similarly,

1992).

1985)In the latter study,

(Meller et

pretreatment with

sulpiride and SCH23390 preferentially protected Dl- and

D2-like binding sites from EEDQ-induced receptor
inactivation

(Meller et al.,

1985). More recent studies

have also shown that peripheral administration of EEDQ
causes substantial reductions of both Dl- and D2-like

receptors on the order of 70-80% and 53-75%,
(Kula,

George,

& Baldessarini,

Rosengarten,

Schweitzer,

& Beardsley,

2000;

receptor recovery,

Zou,

Riddall,

1992;

& Friedhoff,

Cai,

& Jin,

respectively

1993;

1996).

1992;

Undie,

Berki,

In terms of

Dl-like receptor binding sites in the

dorsal striatum were reduced by more than 90% when
measured 6 hr after EEDQ treatment,

however Dl-like

receptors returned to basal levels after 8 days
Pibiri,

Ragatzu,

& Biggio,

1991;

Giorgi,

Pibiri,

(Giorgi,

Dal Toso,

&

1992).

Microinjecting EEDQ into the dorsal striatum causes a
less robust reduction of Dl- and D2-like receptors than

when EEDQ is systemically administered.
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For example,

bilateral administration of EEDQ into the -dorsal striatum

of adult rats reduces Dl-like receptors by as much as 44%
at the injection site and up to 32% when measured 1 mm
away

(Neisewander et al.,

1995).

In a similar vein,

unilateral EEDQ treatment decreases Dl- and D2-like

receptors by 48% and 51%,

respectively, with receptors

returning to basal levels after 7 days

(Giorgi & Biggio,

1990a). Autoradiographic studies have also shown that both

peripheral and central administration of EEDQ causes a
significant loss of striatal Dl- and D2-like receptors

(Cameron & Crocker,
Tarazi,
Weiss,

Kula,

Tarazi,

1989;

Cox & Waszczak,

Baldessarini,
Kula,

& Neumeyer,

& Baldessarini,

In young animals,

1993;

1996;

Zhang,

Zhang,

1999).

systemic administration of EEDQ

causes a potent inactivation of dorsal striatal dopamine
receptors.

Specifically, when measured on PD 17

after EEDQ treatment),

(24 hr

Dl-like binding sites in the dorsal

striatum were reduced by 69-79% depending on EEDQ dose
(7.5-25 mg/kg)

(Crawford et al.,

and 25 mg/kg EEDQ caused a 61%,

respectively,
sites

1992). Likewise,
64%,

7.5,

15,

and 65%,

reduction in dorsal striatal D2-like binding

(Crawford et al.,

1992).

Similarly,

administering 10

mg/kg EEDQ to PD 24 rats reduced the number of Dl- and
D2-like receptors by approximately 74%
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(Kula et al.,

1992). To date, no microinjection studies have assessed
EEDQ-induced dopamine receptor inactivation in preweanling

rats.
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CHAPTER SEVEN
THESIS STATEMENT

Conclusion

The ontogeny of dopamine-mediated motor systems has
not been thoroughly investigated in young animals.

Generally,

research has shown that young and adult animals

respond similarly to Dl- and D2-like agonists.

However,

some behaviors vary across ontogeny due to maturational
changes in dopamine systems

Hedner & Lundborg,

(Broaddus & Bennett,

1985; Lin & Walters,

1990;

1994). Although

much is known about the effects of irreversible dopamine
receptor inactivation in adult animals,

the effects of

EEDQ on dopamine-mediated locomotor activity during early
ontogeny is not fully understood.
Systemic administration of EEDQ attenuates dopamine
agonist-induced behaviors of adult rats,

behaviors of young rats unaffected.

while leaving the

Research from our

laboratory has shown that dorsal striatal infusions of NPA

(5,

10,

or 20 pg)

cause a robust increase in the locomotor

activity of EEDQ-treated preweanling rats

al.,

2011).

(Charntikov et

This effect is opposite to what is observed in

adult rats and suggests that the receptors mediating this

paradoxical behavioral effect are differentially affected
by EEDQ.

59

The overall goals of this thesis were three-fold.
First,

to investigate the effects of intrastriatally

administered EEDQ on NPA-mediated behaviors in both adult
and preweanling rats.

Second,

to use receptor protection

experiments to determine which receptor type is

responsible for EEDQ's paradoxical behavioral effects in

preweanliiig animals.

Third,

to assess the magnitude of

EEDQ-induced Dl- and D2-like receptor inactivation in both

adult and preweanling rats through autoradiography and
receptor binding experiments.

Proposed Hypotheses
In Experiment 1,

I tested whether infusing EEDQ into

the dorsal striatum of adult rats blocks NPA-induced

locomotor activity.

Since previous research has shown that

systemic EEDQ treatment blocks NPA-induced locomotion in
adult rats,

it was hypothesized that microinjecting EEDQ

into the dorsal striatum would block NPA-induced locomotor

activity

(Bordi et al.,

Meller et al.,

1989).

1989; Hamblin & Creese,

1983;

Experiment 2 tested whether EEDQ

paradoxically increases the NPA-induced locomotor activity

of preweanling rats.

In addition,

I examined whether

dopamine receptors were responsible for EEDQ-induced

changes in the NPA-induced locomotor activity of
preweanling rats.

It was hypothesized that Dl- and D2-like

60

receptors in the dorsal striatum are responsible for

mediating NPA-induced locomotor activity.

Because dopamine

receptors were responsible for mediating EEDQ's effects in

preweanling rats I conducted a third experiment.

Experiment 3,

D2-like,

In

I tested whether alterations in Dl-like,

or both Dl- and D2-like receptors underlie the

EEDQ-induced potentiated locomotor response to NPA.

It was

hypothesized-that both Dl- and D2-like receptors are

responsible for the EEDQ-induced locomotor activity of
NPA-treated rats.
In Experiments

4

and 5,

receptor binding and

autoradiography assays were used to quantify Dl- and

D2-like receptor loss after EEDQ infusions in preweanling
and adult animals.

It was hypothesized that intrastriatal

infusions of EEDQ would cause a substantial reduction of

Dl- and D2-like receptor binding sites in preweanling and
adult animals.

It has already been established that-

systemic injections of EEDQ cause robust declines in both

Dl- and D2-like receptors in preweanling and adult rats
(Crawford et al.,

et al.,

1992; Giorgi et al.,

1985).
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1991,

1992;

Meller

CHAPTER EIGHT
GENERAL METHODS

Subjects
Subjects were 252 male and female rat pups of

(Charles River Laboratories,

Sprague-Dawley descent

Hollister,

CA,

San Bernardino

USA),

born and raised at California State,

(CSUSB).

by postnatal day

(PD)

3

Litters were culled to 10 rat pups
(day of parturition is PD 0).

Rats

tested on PD 18 were kept with the dam. Adult male rats
(n=92)

were obtained from Charles River Laboratories and

arrived on PD 59. All rats were group housed until time of
surgery. After surgery,

adult rats were housed singly,

whereas preweanling rats were returned to the dam and

littermates. An approximately equal number of male and
female preweanling rats were randomly assigned to each

group.

Only male rats were used for experiments conducted

during adulthood.

The colony room was maintained at 22-24 °C and kept
under a 12 hr dark/light cycle,

with behavioral testing

occurring during the light phase of the cycle.

water was freely available.

Food and

Subjects were treated

according to the "Guide for the Care and Use of Mammals in
Neuroscience and Behavioral Research"
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(National Research

Council,

2003)

under a research protocol approved by the

Institutional Animal Care and Use Committee of CSUSB.

Apparatus

Behavioral testing was performed in commercially
available activity monitoring chambers
Instruments,

Allentown,

USA)

PA,

separate from the animal colony.
have acrylic walls,

(Coulbourn

housed in a testing room

The activity chambers

a gray plastic floor,

and an open top.

Each chamber included an X-Y photobeam array,
photocells and detectors,

with 16

that was used to measure

horizontal locomotor activity

(distance traveled).

Photobeam resolution was 0.76 cm.
was determined every 100 ms

(i.e.,

The position of each rat

the sampling interval).

To somewhat control for differences in body size,
preweanling rats were placed in smaller chambers

(41 * 41 x 41 cm).

(25 x 25

x 41 cm)

than adult rats

regards,

the different sized chambers were identical.

In all other

Drugs
Sulpiride‘and SCH23390 were dissolved in saline and
administered intraperitonealy

(IP)

to preweanling rats at

a volume of 5 ml/kg. R(-)-propylnorapomorphine

hydrochloride

(NPA)

was dissolved in distilled water

containing 0.1% metabisulfite
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(an antioxidant)

and

administered intracranially at a volume of 0.5 pl per
side. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
(EEDQ) was dissolved in DMSO and injected intracranially

at a volume of 0.75 pl.per side

(Giorgi & Biggio,

1990b).

All drugs were purchased from Sigma-Aldrich (St. Louis,

MO, USA).

Statistical Analysis
Analysis of variance

(ANOVA) were used for the

statistical analysis of locomotor activity data and to
quantify receptor loss. Statistically significant higher
order interactions were further analyzed by one- or

two-way ANOVAs and followed, when necessary, by Tukey

tests

(P<.05). The Huynh-Feldt epsilon statistic was used

to adjust the degrees of freedom (Huynh and Feldt,

1976)

when the assumption of sphericity was violated (determined
by Mauchly's test of sphericity). Corrected degrees of

freedom are represented by a superscripted "a" and rounded
to the nearest whole number.

Litter effects were minimized by assigning precisely
one subject from each litter to a particular group

discussion of litter effects,

see Zorrilla,

(for a

1997). Unlike

adults, prepubescent rats do not typically exhibit sex

differences after treatment with dopamine agonists
also Bowman et al.,

(see

1997; McDougall, Garmsen, Meier,
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&

Crawford,

1998).

2007;

Scalzo & Holson,

Therefore,

1992;

Snyder et al.,

both males and females were tested at PD

18 and statistically significant sex effects were not

evident.

Male .rats will be exclusively used at PD 85.
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CHAPTER NINE
BEHAVIORAL PROCEDURES

Intracranial Cannulation Surgery
Cannulae implantation surgeries were performed on PD

16 and PD 83

(two days prior to behavioral testing). At

both ages,

anesthesia was induced by administering

isoflurane

(5%/5min in 100% oxygen during the induction

2-3% in 100% oxygen during the maintenance phase)

phase,

via a nose mask.

Prior to surgeries,

topical lidocaine solution

IP)

(1%)

all rats were given a

and ketoprofen

(2 mg/kg,

for pain management. A Kopf stereotaxic apparatus was

u’sed,

with preweanling rats requiring a Cunningham

Neonatal Rat Adapter for proper positioning.

Stereotaxic

coordinates for the dorsal striatum have been obtained
from the developing rat brain atlas of Sherwood and

Timiras

(1970)

for preweanling animals and from the rat

brain atlas of Paxinos and Watson

(1998)

for adult rats.

Two craniotomies were performed and either a
stainless steel double guide cannula

two single guide cannulae

(preweanling rats)

were implanted in

(adult rats)

the dorsal striatum of preweanling rats

(A +6.5,

L ±2.4,

(A +0.20,

-5.6 from interaural line)

and adult rats

+3.1, V -5.7 from bregma).

Both sets of guide cannulae

(22-gauge;

Plastics One,

Roanoke,
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VA)

or

V

L

were implanted 1 mm

above the target location.

In preweanling rats,

bilateral

guide cannulae were anchored to the scull using

cyanoacrylate gel followed by dental cement
Wheeling,

USA).

IL,

For adult rats,

(Lang Dental,

individual guide

cannulae were fixed in place using two stainless steel
anchor screws and cyanoacrylate gel followed by dental

cement.

In both age groups,

(Plastics One)

stainless steel stylets

were used to seal the guide cannula until

time of testing.

Following cranioplasty,

all rats were

sutured and placed in a heated incubation chamber for 2-4
hr.

Post-operative monitoring was performed in order to

assess subject responsiveness. All rats underwent
behavioral assessment 48 hr after surgery.

Microinjection Procedure
Stainless steel stylets were replaced by infusion

cannulae

(28-gauge;

Plastics One),

the tip of the guide cannula.

Infusion cannulae were

attached via polyethylene tubing
Sparks,

MD,

USA)

(28 mm;

Becton Dickinson,

to Hamilton microsyringes

controlled by dual infusion pumps
Instruments,

which extend 1 mm below

Sarasota,

FL,

USA).

(10 pl)

(World Precision
Cannulae were left in

place for 1-2 min and then the drug was delivered at a

constant rate over a 60 s period.
microinjection,

Following

cannulae were left in place for an
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additional 1-2 min after which rats were returned to the
activity monitoring chambers.

Distance traveled

of horizontal locomotor activity)

(a measure

was assessed

continuously across the 80-min session

40 min of

(i.e.,

habituation and 40 min of drug testing).

Procedures
Experiment 1. Effects of EEDQ on NPA-Mediated
Behaviors of Adult Rats

Overview.

The first experiment was conducted to

determine whether intrastriatal infusions of EEDQ are
capable of blocking NPA-induced locomotor activity in
adult rats.

This was a between-subject design with two

independent variables:
post-drug

condition

(0 or 20 pg NPA).

distance traveled scores,

(EEDQ' or DMSO)

The dependent variable was

which was assessed in automated

activity chambers. A total of 33 rats
were used in Experiment 1

Methodology.

On PD 84

and

(Figure 2,

(n = 8-9 per group)
Top Panel).

(24 hr after surgery),

received bilateral infusions of DMSO or EEDQ
pl per side). After an additional 24 hr

rats

(100 pg;

(i.e.,

0.75

on PD 85),

EEDQ- and DMSO-treated rats were placed in the automated
locomotor activity chambers for 40 min.
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following this 40 min baseline period, rats were
micro.injected with either distilled water or NPA (20 pg;

0.50 pl per side)

into the dorsal striatum. Rats were then

returned to the activity chambers for another 40 min,

where .locomotdr activity was recorded. After behavioral
testing,

all subjects underwent histological examination.

.-Experiment 2., Role of DI- and D2-Like Striatal
"Receptors in EEDQrMediated Behaviors of
Preweanling Rats
Overview. The second experiment was conducted to
determine whether intrastriatal infusions of EEDQ block

NPA-induced locomotor activity in preweanling rats. This
experiment was also done to determine whether dopamine

receptors located in the dorsal striatum mediate

EEDQ-induced alterations in locomotor activity. This was a

between-subject design with three independent variables:

pretreatment group

(combination of SCH23390/sulpiride or

saline), condition

(EEDQ or DMSO), and post-drug (e.g.,

0,

10, or 20.pg NPA). The dependent variable was distance
traveled scores. A total of 96 rats

used in Experiment 2

(n = 8 per group) were

(Figure 2, Middle Panel).

Methodology. On PD 17

(24 hr after cannulae

implantation), different groups of rats were systemically
treated (IP) with saline or a combination of SCH23390
mg/kg)

and sulpiride

(100 ntg/kg)
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30 and 60 min,

(1

respectively,

before receiving intracranial drug infusions
1989;

(Cameron & Crocker,

Biggio,

1990b).

Crawford et al.,

1992;

Giorgi &

Groups were further subdivided with

saline- or SCH23390/sulpiride-protected rats receiving

bilateral infusions of EEDQ

(100 pg;

0.75 pl per side)

or

DMSO into the dorsal striatum.

On PD 18

(i.e.,

24 hr after EEDQ or DMSO treatment),

preweanling rats were habituated to the automated testing
chambers for 40 min.

Rats then received dorsal striatal

infusions of either distilled water or NPA

0.50 pl per side)

(10 or 20 pg;

and locomotor activity was assessed for

an additional 40 min. All rats underwent histological
examination upon completion of behavioral testing.

Experiment 3. Effects of Dl- or D2-Like Striatal
Receptor Inactivation on EEDQ-induced Behaviors of
Preweanling Rats
Overview.

Experiment 2 showed that EEDQ's actions are

mediated by dopamine receptors and therefore a third
experiment was conducted.
determine whether Dl-like,

Experiment 3 was done to
D2-like,

or both Dl- and

D2-like receptors located in the dorsal striatum mediate
the EEDQ-induced behavioral effects of preweanling rats.

This was a between-subject design with three independent

variables:

saline),

pretreatment group

condition

(SCH23390,

(EEDQ or DMSO),
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sulpiride,

and post-drug

or

The dependent variable was

(distilled water or NPA).

distance traveled scores. A total of 104 rats

were used in Experiment 3

group)

Methodology.

On PD 17,

injection of SCH23390
saline.

(Figure

Bottom Panel).

all rats received a systemic

(1 mg/kg),

sulpiride

(100 mg/kg)

or

SCH23390 was administered 30 min prior to EEDQ

(100-pg;

0.75 pl per side)

or DMSO infusions,

sulpiride was injected 60 min before

1989; Crawford et al.,

PD 18

2,

(n = 8 per

(i.e.,

1992;

whereas

(Cameron & Crocker,

Giorgi & Biggio,

1990b).

On

24 hr after EEDQ or DMSO treatment),

preweanling rats were habituated to the automated testing

chambers for 40 min.

Rats then received dorsal striatal

infusions of either distilled water or NPA
per side)

(.10 pg;

0.50 pl

and locomotor activity was assessed for an

additional 40 min. All rats underwent histological

examination upon completion of behavioral testing.

Histology
After behavioral testing,

rats were given an overdose

of sodium pentobarbital and brains were fixed in'a 4%

paraformaldehyde solution for 48-72 hr.

Brains were then

cryoprotected in a 20% sucrose solution

(24-48 hr),

sectioned coronally
with thionin.

(70 pm)

using a cryostat,

and stained

Histological assessment of cannulae

placement was performed by an observer blind to
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experimental conditions. Cannulae placement was

graphically mapped on coronal sections taken from Paxinos

The rat brain: in stereotaxic coordinates

and Watson's
(1998).

Only subjects with accurate cannulae placements

were included in the statistical analysis.

Cannula

placements of rats included in the statistical analyses

are shown in Appendix A.

Statistical Analysis
For Experiment 1,

variables:

a)

there were two independent

condition

(EEDQ or DMSO)

(Figure 2).

(distilled water or 20 pg NPA)

used to analyze time blocks 1-8
(agonist testing).

eight tiriie blocks

time blocks 9-16
8

Because of

and time

(habituation)
Specifically,

the first

were analyzed using a 2 * 8

(0-40 min)

(condition x time block)

post-drug

separate ANOVAs were

ongoing experimental manipulations,

blocks 9-16

and b)

repeated measures ANOVA; whereas,
were analyzed using a 2 x 2 x

(40-80 min)

(condition x post-drug x time block)

repeated measures

ANOVA.
For Experiments 2 and 3,
variables:

b)

a)

condition

receptor protection

(EEDQ and DMSO),

water and NPA).

2x8

there were three independent

(pretreatment groups),

and c)

post-drug

(distilled

Time blocks 1-8 were analyzed using a 2 x

(Experiment 2)

and 3x2x8
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(Experiment 3)

(pretreatment x condition * time block)
ANOVA.

8

repeated measures

Time blocks 9-16 were analyzed using a 2 * 2 * 3 *

(Experiment 2)

and 3 * 2 * 2 * 8

(Experiment 3)

(pretreatment x condition x post-drug x time block)
repeated measures ANOVA.
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CHAPTER TEN
NEUROCHEMICAL PROCEDURES

Intracranial Infusion Surgery
'The procedures for this surgery were similar to those

of the intracranial cannulation surgeries,
following exceptions.,

but with the

Bilateral burr holes were made above

the dorsal striatum on PD 17 or PD 84 using the following
coordinates: A +6.5,
line

L +2.4,

(preweanling rats)

bregma

V -6.6 from the interaural

and A +0.20,

L ±3.1,

V -6.7 from

(adult rats). Needles were slowly lowered into the

dorsal striatum and bilateral injections of EEDQ.or DMSO

,(0/75 ul)

were made over 2 min.

The syringe was left in

place for 2 min prior to and after the infusions.

holes were sealed using Gelfoam (Upjohn,
USA). All rats were sutured,
IP),

The burr

Kalamazoo,

given ketoprofen

MI,

(2 mg/kg

and placed in incubators for 2-4 hr prior to being

returned to their home cages.
Experiment 4.

Quantitative Autoradiography

A total of 20 adult and 20 preweanling rats

per group)

were used.

(n = 5

Rats of both age groups received

bilateral infusions of EEDQ

(100 pg;

0.75 pl)

or DMSO

(Figure 3). Animals were decapitated and brains were
rapidly removed 24 hr after surgery
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(i.e.,

on PD 18 and

rIntracranial Receptor

--------- ~j

Inactivation
(PD 17/PD84)
•EEDQ

Experiments 4 & 5

•DMSO

<>
Figure 3.

Schematic Representing the Experimental Design

Used in Experiment 4 and Experiment 5

EEDQ,

(EEDQ vs.

DMSO).

Irreversible Monoamine Receptor Alkylating Agent
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PD 85).

Once extracted,

brains were immediately immersed

in isopentane at -30°C for 2 min to promote uniform

freezing,

and then stored at -80°C until time of assay.

■Brains were sectioned in the coronal plane at a
thickness of 20 pm at -18 °C.

Sections were thaw-mounted

onto electrostatically coated slides
Fisher Scientific,
vacuum,

Pittsburgh,

PA),

(Superfrost Plus;
air-dried under

and stored at -80°C until assayed for radioligand

binding. At time of assay,

sections were thawed at room

temperature for 5 min and preincubated in 50 mM Tris HC1
for 30 min.

(pH 7.4)

Slides were incubated in 50 mM Tris

buffer -containing either 2 nM

[3H]SCH23390

(to label

Dl-like receptors)

or 0.15 nM

D2-like receptors)

for 30 min at room temperature.

[3H]spiperone

(to label

Nonspecific binding was determined in the presence of
10 pM

(+)butaclamol

(-)-sulpiride

(for the Dl assay)

or 10 pM

(for the' D2 assay). After labeling,

were washed in ice cold Tris buffer

sections

(3 washes for 20 s)

and then dried under a stream of cold air.

The sections

were apposed to. ,[3H] -sensitive along with calibrated

standards

( [3H]microscales;

GE Healthcare,

Piscataway,

Jersey,

USA)

period,

autoradiograms were analyzed using a

for 10 weeks at -20°C.

computer-assisted image analyzer
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New

Following the exposure

(MCID,

InterFocus

Imaging, Cambridge,

England).

Optical density was

converted into nCi/mg of radioligand bound using a
standard curve as a reference.

Cannula placements were

determined during tissue sectioning by drawing the cannula
tracts at each plate of the atlas of Paxinos and Watson

(1986)

for adult rats and Sherwood and Timiras

preweanling rats.

(1970)

for

The lowest point of the tract was

estimated as the site of infusion.
Experiment 5. Dl- and D2-Like Homogenate Ligand
Binding Conditions

All rats received bilateral infusions of either EEDQ
or DMSO on PD 17 or PD 84
(24 hr after surgery),

On PD 18 or PD 85

(Figure 3).

71 rats

adult and 48 preweanling rats)

(n = 5-6 per group;

23

were killed by rapid

decapitation and dorsal striatal sections were dissected

bilaterally and-stored at -80°C until time of assay.

Homogenates from two PD 18 rats were combined to serve as
a .single subject for both the Dl. and D2 assay.

day,

On assay

tissue was thawed on ice and crude membrane

homogenates were made using the following protocol.
Striatal sections from each rat were homogenized in 100
i

volumes of 50 mM Tris-HCl buffer

(pH ,7.4)

■-

for

approximately 20 s using a Brinkmann Polytron.

The

homogenates were centrifuged at 20,000 x g for 20 min.
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The

pellet was resuspended in 100 volumes of the same buffer

and centrifuged again at 20,000 x g for 20 min.
The final pellet was suspended in approximately 30

volumes of buffer (pH 7.4). Protein concentrations for the

final pellet were determined using the Bio-Rad Protein

Assay, with BSA as the standard.

For both DI- and D2-like

receptor binding, tissue suspension's

(15-30 pg/protein)

were added to duplicate tubes containing 50 mM Tris,

NaCl2, 5 mM KC1,

1 mM MgSO4, and 2 mM CaCl2

2 mM

(pH 7.4) at a

final volume of 1 ml. Concentrations ranging from

0.1-5.0 nM of [3H]SCH23390

nM [?H]spiperone

(for the DI assay) or 0.05-0.9

(for the D2 assay) were added to the

100 nM of mianserin was also
I
added to the tubes to prevent binding of [3H]SCH23390 to

tubes. For the DI assay,

serotonin receptors.

Due to the specificity of sulpiride,

mianserin was not used in the D2 assay (Boyson, McGonigle,
I
& Molinoff, 1986). The incubation time was 30 min at 37°C.
Incubation was terminated by vacuum filtration over glass

fiber filters

(Whatman GF/B, pretreated with 0.1%

polyethylenimine). Filters were washed twice with ice-cold
Tris-HCl buffer and radioactivity was measured by liquid
i
scintillation spectrometry. Non-specific binding was

determined in the presence of 10 pM (+)-butaclamol

(for DI

assay) or 10 pM (-)-sulpiride (for D2 assay). Specific
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binding was defined as the difference in

[3H]SCH23390

bound in the presence and absence of 10 pM
or as the difference in

(’+) -butaclamol

[3H] spiperone bound in the

presence and absence of 10 pM

(-)-sulpiride.

Statistical Analysis
■

For Experiment 4,

t'-tests

(condition:

autoradiograms were analyzed using

EEDQ and DMSO)

at each age to assess

Dl- and.D2-like receptor densities. Additionally,
2-2

(condition x age)

separate

ANOVAs were conducted to analyze

receptor densities across ontogeny.

For the homogenate

binding .experiments

Dl- and D2-like

(Experiment 5),

receptor binding sites

(E^ax)

and affinity

(KD)

data from

the homogenate ligand binding assays was determined using

non!inear regression with Prism

Diego,
t-tests

CA,

USA) .

Bmax and

(condition:

Additionally,

(GraphPad Software,

San

values were analyzed using

EEDQ and DMSO)

separate 2*2

at each age.

(drug * age)

ANOVAs were used

to analyze Dl- and D2-like receptor Bmax and
ontogeny.
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KD

across

CHAPTER ELEVEN
RESULTS

Experiment 1
Effects of EEDQt on the NPA-induced Behaviors of
Adult Rats
Habituation Phase.
phases

(i.e.,

During the chamber habituation

time blocks 1-4 and 5-8),

EEDQ-treated adult

rats had significantly lower distance traveled scores than
(Figure 4,

controls

F(l,31)

= 20.02,

respectively].

left panel)

P<

0.001;

[Condition main effects,

F(l,31)

= 19.90,

P<

0.001,

Distance traveled scores were elevated

immediately after rats were placed in the activity
but scores then declined to a stable baseline on

chambers,

time block 7

P <

0.001;

[aTime Block main effects,

F(3,93)

= 38.68,

P <

0.001,

F(3,79)

= 116.41

respectively,

and

Tukey tests].

Testing Phase.

During the testing phase

blocks 9-16), bilateral infusions of NPA

(i.e.,

(20 pg)

time

caused a

significant increase in distance traveled scores for only
the DMSO-treated rats

inset)

(Figure 4,

right panel and see

[Condition x Post-Drug interaction,

P<0.05].

In contrast, microinjecting NPA

F(l,29)=5.73,

(20 pg)

into the

dorsal striatum of EEDQ-treated rats had minimal effect on

locomotor activity because distance traveled scores
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5-Min Time Blocks

A Significantly different than DMSO/DW group on time blocks 5-8.
* Significantly different from all other groups,
t Significantly different from DW controls.
Figure 4. Mean Distance Traveled

(±SEM)

Behavioral Testing Session on PD 85

During the 80-min

(n - 8-9 per Group)

Experiment 1. At the Conclusion of Time Block 8

by the Dashed Line),

of

(Indicated

Rats Previously given Bilateral

Infusions of DMSO or EEDQ

(100 pg)

into the Dorsal

Striatum Received Bilateral Infusions of Distilled Water

or NPA

(20 pg).

Inset Represents Mean Distance Traveled

Scores Collapsed Across Time Blocks 9-16.
EEDQ/DW;

(□) DMSO/NPA;

(■)

EEDQ/NPA.
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(o)

DMSO/DW;

(•)

remained at a low,
controls.

stable rate that was similar to

Individual time block analysis showed that

microinjecting NPA

(20 pg)

into the dorsal striatum caused

an increase in locomotor activity on time blocks 14-16

[aPost-Drug x Time Block interaction F(5,152)=10.91,

P<0.001,

and Tukey tests].

These results indicate that

EEDQ fully attenuates NPA's locomotor enhancing effects in
adult rats.
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Experiment 2
Role of Dl- and D2-Like Striatal Receptors for the
EEDQ-induced Behaviors of Preweanling Rats
Habituation Phase.

phases

(i.-e.,

During the chamber habituation

time blocks 1-4 and 5-8),

distance traveled

scores were significantly affected by the pretreatment and

condition variables
EEDQ vs.

(i.e.,

DMSO)(Figure 5,

SCH23390/sulpiride vs.

saline;

panels to the left of dashed

vertical lines)[Pretreatment x Condition interactions,
F(l, 92)=8.95,

F(1,92)=5.51,

P<0.05;

Specifically,

rats treated with either EEDQ or

P<0.01,

respectively].

SCH23390/sulpiride had significantly greater distance

traveled scores than the control group

Protection group)[Tukey tests].
D2 receptors,

(i.e.,

Therefore,

the DMSO/No

blocking Dl and

either reversibly or irreversibly,

increased

basal distance traveled scores. Although the Pretreatment
x Condition x Time Block interaction did not reach
significance,

.

■

EEDQ-treated rats did have significantly

greater distance traveled scores than DMSO controls on
time blocks 6-8

[Condition x Time Block interaction,

F(2,178)=20.98,

P<0.001,

Testing Phase.
blocks 9-16),

and Tukey tests].

During the testing phase

(i.e.,

time

EEDQ-treated rats had significantly greater

distance traveled scores than DMSO-treated rats
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(Figure 5,

Preweanling Rats
5,000

EEDQ - No Protection

DMSO - No Protection

4,000

3,000
■2,000
■1,000
■0

EEDQ - SCH/Sul Protection

GSCH/Sul Protection

t

Q)

O
£2
W

.4,030-

2
Q

3,000-

■•7- DMSO

4F-

O 0 pg NPA

■4,000

0 pg NPA

EEDQ
i
i

10 pg NPA
O 20 pg NPA

•A- 10 pg NPA

■* 20 pg NPA

I

■3,000
■2,000
■1,000

14 5

6

7

8

9 10 il 12 13 14 15 16

1-4 5

7

6

8

9 io il 12 13 14 15 1R

5-Min Time Blocks
* Significantly different from DMSO-treated rats.
A Significantly different from the DMSO/No Protection condition (collapsed across time
blocks 1-4 and 5-8).
t Significantly different from rats in the other treatment conditions infused with 10 or
20 pg NPA (collapsed across time blocks 9-16).
+ Significantly different from rats in the same treatment condition infused with 0 pg
NPA (collapsed across time blocks 9-16).
Figure 5.

Mean Distance Traveled

(+SEM)

Behavioral Testing Session on PD 18

Experiment 2.

Rats were Previously

During the 80-min

(n = 8 per group)
(i.e.,

PD 17)

of

Injected

with Saline or SCH23390/sulpiride and given Bilateral
Infusions of either DMSO or EEDQ

(100 pg)

into the Dorsal

Striatum. At the Conclusion of Time Block 8
indicated by the dashed line),

Rats Received Bilateral

Infusions of Distilled Water or NPA
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(PD 18;

(10 or 20 pg).

panels to the right of dashed vertical lines)

main effect,

F(l,84)=28.68,

[Condition

P<0.001]. However,

the'

locomotor enhancing properties of EEDQ were only evident
in the EEDQ-No Protection group
interaction,
Specifically,

F(l,84)=25.39,

[Pretreatment x Condition

P<0.001,

the EEDQ-treated group that received no

receptor protection

(i.e.,

inactivated by EEDQ),

Dl- and D2-like receptors were

exhibited greater distance traveled

scores than both DMSO-treated groups

lower left graphs)
(Figure 5,

and Tukey tests].

(Figure 5,

upper and

as well as the EEDQ-Protected group

lower right graph).

Infusing NPA

(10 or 20 pg)

into the dorsal striatum

caused a significant increase in locomotor activity
[Post-Drug main effect,

tests].

F( 2,84)=32.09,

P<0.001,

and Tukey

The effects of the agonist varied according to

protection condition

interaction,

[Pretreatment x Post-Drug

F(2, 84)=5.07,

P<0.01].

Specifically,

NPA-treated rats in the receptor protection groups
the SCH23390/sulpiride groups)

(i.e.,

had smaller distance

traveled scores than NPA-treated rats in the No Protection

groups.

Even though the Pretreatment x Condition x Post-Drug
x Time Block four-way interaction was not significant,

86

two

three-way interactions involving time block were

statistically significant
Time Block interaction

[aPretreatment x Post-Drug x

F( 14,288)=2.05,

x Post-Drug x Time Block interaction,
P<0.05]. Most importantly,

P<0.05; aCondition

F( 14,288)=1.88,

EEDQ treatment caused an

increase in locomotor activity scores across time blocks

[Condition x Time Block interaction,

P<0.001].

F(3,288)=8.51,

This potentiated locomotor effect was completely

eliminated when EEDQ-treated rats received receptor
protection

(i.e.,

SCH23390/sulpiride) ,

because distance

traveled scores of the EEDQ-Protection group were similar
to rats pretreated with distilled water and infused with
DMSO

(Figure 5,

top left and bottom right panel).

Thus,

NPA potentiated the locomotion of preweanling rats only if
DI- and D2-like receptors were simultaneously inactivated

by EEDQ.
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Experiment 3
Effects of DI- or D2-Like Striatal Receptor
Inactivation on the EEDQ-Induced Behaviors of
Preweanling Rats
Habituation .

(i.e.,

During the chamber habituation phases

time blocks 1-4 and 5-8),

distance traveled scores

were significantly affected by condition

DMSO)(Figure 6,

panels to the left of dashed vertical

lines)[Condition main effects,
F(l, 90)=68.78,

(EEDQ or

P<0.001,

F(l,90)=14.88,

respectively].

P<0.001;

Specifically,

EEDQ-treated rats had greater distance traveled scores

when compared to DMSO-treated rats.

Individual time block

analysis showed that EEDQ-treated rats had significantly

greater distance traveled scores than all DMSO-treated
rats on time blocks 5 and 7

interaction,

[Condition x Time Block

F(5,406)=34.29,

Testing Phase.

blocks 9-16),

P<0.001,

and Tukey tests].

(i.e.,

During the testing phase

EEDQ-treated rats had significantly greater

distance traveled scores than rats receiving DMSO
6,

time

(Figure

compare panels to the right of the dashed vertical

line)

[Condition main effect F(l,84)=35.65,

Regardless of pretreatment

sulpiride)

(i.e.,

saline,

P<0.001].

SCH23390,

and receptor inactivation conditions

EEDQ or DMSO),

microinjecting NPA

(10 pg NPA)

or

(i.e.,

into the

dorsal striatum caused a significant increase in distance
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Preweanling Rats
5,000

T DMSO - No Protection

EEDQ - No Protection

4,000

■4,000
I

■3,000

3,000I

■2,000

2,000-

■1,000

1,000-

V

E
u
TJ,
0)
d)
>
£5
H
0)
o
c
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h

G-

0

EEDQ - SCH Protection

DMSO - SCH Protection

■4,000

4,000;

■3,000

3,000I

■2,000

2,000-

■1,000

1,000'

V
0-

V—V—V-V;

0

EEDQ - Sul Protection

DMSO - Sul Protection

■4,000

4,000'
-v- DMSO

3,000

■3,000
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1-4 5
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1-4 5

6

7

8
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10 11

12 13 14 15 16

5-Min Time Blocks
* Significantly different from the DMSO condition.
A Significantly different from the DMSO condition (collapsed across time blocks 1 -4 and 5-8).
£ Significantly different from the DMSO condition with the same pretreatment (i.e., No
Protection, SCH23390, or sulpiride) receiving 10 pg NPA group (collapsed across time
blocks 9-16).
~ Significantly different from rats in the same treatment condition infused with 0 pg NPA at the
same time block.
t Significantly different from rats in the same treatment condition infused with 0 pg NPA
(collapsed across time blocks 9-16).
t Significantly different from DMSO group with the same pretreatment (i.e., No Protection,
SCH23390, or sulpiride) receiving 10 pg NPA group at the same time block.
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Figure 6, Mean Distance Traveled

(+SEM)

- Behavioral'Testing Session on PD 18
Experiment 3.

with Saline,,

Rats were Previously
SCH23390,

During the 80-min

(n =
(i.e.,

8 per group)

PD 17)

of

Injected

or Sulpiride and given Bilateral

Infusions of either DMSO or EEDQ

(100 pg)

into the Dorsal

Striatum. At the Conclusion of Time Block 8
indicated by the dashed line),

Rats Received Bilateral

Infusions of Distilled Water or NPA
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(PD 18;

(10 pg).

traveled scores when compared to rats receiving 0 pg NPA

[Post-Drug main effect,
More importantly,

interaction

F(l,84)=101.87,

there was a significant four-way

(Figure 6) [aPretreatment x Condition x

Post-Drug x Time Block interaction,
P<0.001].

P<0.001].

F(7,307)=3.61,

Due to this higher-order interaction,

two-way ANOVAs were conducted.

three

Each Condition x Time Block

ANOVA compared NPA-treated rats given either DMSO or EEDQ.

A separate ANOVA was conducted for each protection
condition

(i.e.,

No Protection,

SCH23390 Protection,

and

sulpiride Protection). An individual time block analysis

of the No Protection groups

(upper graphs,

Figure 6)

showed that NPA caused a potentiated locomotor response in

EEDQ-treated rats on time blocks 9-11

(i.e.,

when compared

to DMSO-treated rats receiving NPA) [Condition x Time

Block interaction,

Likewise,

F(3,45)=3.80,

P<0.05,

and Tukey tests].

when comparing the SCH23390 Protection groups

(middle graphs,

Figure 6),

NPA caused a potentiated

response in EEDQ-treated rats on time blocks 9-11 and

13-16) [aCondition x Time Block interaction,
P<0.05,

and Tukey tests]. And,

sulpiride Protection groups

F(4,50)=3.80,

when comparing the

(lower graphs,

Figure 6),

NPA

caused a potentiated response in EEDQ-treated rats on time
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Preweanling Rats
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5-Min Time Blocks
* Significantly different from EEDQ-treated rats infused with 10 pg NPA in the
SCH23390 Protection group (collapsed across time blocks 9-16).
t Significantly different from EEDQ-treated rats infused with 10 pg NPA in the
SCH23390 only and sulpiride only Protection groups at that same time block.
t Significantly different from EEDQ-treated rats infused with 10 pg NPA in combined
SCH23390/sulpiride Protection group at that same time block.

Figure 7. Mean Distance Traveled

(+SEM)

Behavioral Testing Session on PD 18

Experiment 3.

Rats were Previously

with Combined SCH23390/sulpiride,

During the 80-min

(n = 8 per group)

(i.e.,

PD 17)

SCH23390 alone,

Injected

or

Sulpiride Alone and given Bilateral Infusions of EEDQ
pg)

of

(100

into the Dorsal Striatum (the SCH23390 alone and

sulpiride alone rats are from Figure 6). At the Conclusion

of Time Block 8

(PD 18;

indicated by the dashed line),

Rats Received Bilateral Infusions of NPA
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(10 pg).

blocks 13-16) ^Condition x Time Block interaction,
i

F(3, 37)=6.05,

P<0.01,

and Tukey tests].

In this experiment an additional group of 8 rats were

infused with NPA 24 hr after receiving combined
SCH23390/sulpiride pretreatment and EEDQ

were treated as in Experiment 2). A3 x 8

(i.e.,

these rats

(Pretreatment x

1

Time Block) ANOVA was conducted to compare EEDQ-treated rats

infused with NPA within the three protection groups
SCH23390,

sulpiride,

(i.e.,

or combined SCH23390/sulpiride).

EEDQ-treated rats in the combined SCH23390/sulpiride

protection group had smaller distance traveled scores than

EEDQ-treated rats in the SCH23390 protection group infused
i

with NPA (Figure 7)[Pretreatment main effect,

P<0.05,

and Tukey tests].

Importantly,

F(2,21)=4.64,

EEDQ-treated rats

given SCH23390 Protection did not differ from rats given

sulpiride Protection. Additionally,

the effects of NPA on

distance traveled scores varied across time blocks
[aPretreatment x Time Block interaction, ' F(6,68)=7.01,

P<0.001,

and Tukey tests].

Specifically,

the combined

SCH23390/sulpiride protection group differed from both the
SCH23390 alone and sulpiride alone protection groups on time
i

blocks 13-15,

from the SCH23390 alone protection group on

time blocks 10-12,

and from the sulpiride alone protection

group on time block 16.

Experiment 4
Quantitative Autoradiography
Representative Dl- and D2-like receptor

autoradiograms of EEDQ- and DMSO-treated rats are shown in

Appendix B

(preweanling rats)

and Appendix C

Autoradiograms were analyzed using t-tests

EEDQ and DMSO)

(adult rats).

(condition:

at each age to assess Dl- and D2-like

receptor densities. Additionally,
(condition * age)

separate 2*2

ANOVAs were conducted to analyze

receptor densities across ontogeny.

[3H]SCH23390 Autoradiography
Intrastriatal EEDQ injections significantly reduced

Dl-like receptor densities in both preweanling and adult
rats

(see Table 1)[t(8)=7.70,

PC0.001;

t(8)=8.41,

PC0.001,

respectively].
[3H]Spiperone Autoradiography

Microinjecting EEDQ into the dorsal striatum caused a
significant reduction in D2-like receptor binding sites in

(see Table 1) [ t (7)

both 'prewean-ling and adult rats
P < 0.01;

t(8)

= 4.53,

P < 0.01,

= 3.92,

respectively].

Ontogenetic Differences

A 2 x 2

(Age x Condition)

Dl-like receptor densities.

ANOVA was used to assess

Microinjecting EEDQ into the

dorsal striatum of both preweanling
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(30%)

and adults

(34%)

Table.1.- Quantitative
Determine

in Vitro

[3H]SCH23390 and

Autoradiography Used to

[3H]spiperone Labeling

Intensities in Coronal Sections of the Dorsal Striatum
after Intrastriatal Microinjections of DMSO and EEDQ in

■.Preweanling and Adult Rats

- Treatment’

PD 18
DMSO
EEDQ

Kax (fmol/mg protein)
Dl-like receptors

19.17

(±1.63)

8.12

(±0.29)b

5.71

(±0.95)a

4.85

(±0.56)ab

%DMSO

PD .85
DMSO

EEDQ

%DMSO

Bmax (fmol/mg protein)
D2-like receptors

60%

30%

22.10

(±1.41)

15.28

(±2.58)

7.56

(±1.06)a

5.50

(±0.57)a
36%

34%

Preweanling and adult rats received bilateral infusions of
DMSO ox EEDQ (100 mg/kg) on PD 17 and PD 84, respectively.
Tissue was harvested 24 hr after EEDQ or DMSO infusions.
a Significantly different from DMSO-treated rats of the
same age; b Significantly different from EEDQ-treated PD
85 rats.
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rats significantly reduced

[3H]SCH23390 binding,

effect did not vary according to age
main effect,

F(l,16)

= 129.88

P

and this

(Figure 8)[Condition

< 0.001].

In contrast,

adult rats had markedly more dorsal striatal D2-like

receptors than preweanling rats
effect,

F(l,5)

significantly reduced
striatum

P <

P <

= 10.02

(see Table 1)[Age main

0.0'1].

[3H]spiperone binding in the dorsal

[Condition main effect,

0.001],

EEDQ infusions

F(l,15)

= 28.05

and this effect varied between age groups

x Condition interaction,
specifically,

F(l,15)

= 6.99

P <

0.05].

[Age

More

D2-like receptor densities were reduced to

60% in preweanling rats; while,

in adult rats,

EEDQ

reduced D2-like receptor densities to 36% of control

values.
Taken together,

these data show that adult and

preweanling rats have similar levels of Dl-like receptors
in the dorsal striatum,

while adults have approximately ■

twice the number of D2-like receptors.

EEDQ caused similar

reductions of Dl-like receptor densities in preweanling
and adult rats.

Interestingly,

EEDQ depleted the D2-like

receptors of preweanling rats to a lesser extent than

adults.
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Autoradiography
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t Significantly different from DMSO-treated rats of the same age.
t Significantly different from EEDQ-treated PD 85 rats.

Figure 8.

on

Effects of Intrastriatal Microinjections of EEDQ

[3H]SCH23390 and

Receptors,

[3H]Spiperone

Respectively)

(i.e.,

Dl- and D2-like

Densities in Dorsal Striatal

Coronal Sections of Preweanling and Adult Rats. Values
Represent Percent Change from DMSO-treated Control Rats

(100%) .
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Experiment 5
Dl-Like Receptor Binding

When assessed on PD 18,
densities

were significantly reduced 24 hr after

(Bmax)

EEDQ infusions

(Table 2)

Dl-like receptor affinity

KD

with the overall

Similarly,

Dl-like receptor binding site

[t(10)

(KD)

= 5.70,

P <

0.001].

was not altered by EEDQ,

value being 0.840

(±0.138)

nM.

infusing EEDQ on PD 84 caused a

significant decrease in Dl-like receptor binding site

densities

(Table 2)

(t(9)

= 6.11,

to the preweanling age group,

P

< 0.001].

In contrast

EEDQ infusions significantly

enhanced KD values in the dorsal striatum of adult rats

P

=2.40,

[t(9)

< 0.05].

D2-Like Receptor Binding

Infusing EEDQ into the dorsal striatum of PD 17 rats
caused a significant decrease in D2-like receptor binding

site densities when assessed 24 hr later
[t(10)

= 3.16,

P

< 0.05].

(Table 3)

D2-like receptor affinity was

not altered when EEDQ was infused into the dorsal stratum.

Although EEDQ infusions on PD 79 caused a substantial

decrease in D2-like receptor binding like densities

35% reduction),
significance

(i.e.,

this effect did not reach statistical

(Table 3)

[P =

0.12].
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However,

the mean KD

Effect of DMSO and EEDQ on Dl-like Receptor

Table 2.
Density
for

(fmol/mg Protein,

±SEM)

and Affinity

(nM,

±SEM)

[3H]SCH23390 Binding in the Dorsal Striatum of

Preweanling and Adult Rats

Treatment

PD 18 (n=12)
DMSO
EEDQ

(100 mg/kg)

PD 85 (n=ll)
DMSO

%DMSO

(fmol/mg protein)

3631.44b

802.28a

(±483.63)
(±110.98)

Fa

(nM)

0.699

(±0.098)

0.981

(±0.258)

0.684

(±0.055)

22%

%DMSO

EEDQ

Bmax

(100 mg/kg)

4771.8
1413.4a

(±459.01)

(±234.78)

1.069'1

(±0.166)

30%

Preweanling and adult rats received bilateral infusions of
DMSO or EEDQ (100 mg/kg) on PD 17 and PD 84, respectively.
Tissue was harvested 24 hr after EEDQ or DMSO infusions.
a Significantly different from DMSO-treated rats of the
same age; b Significantly different from PD 85 rats.
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Effect of DMSO and EEDQ on D2-like Receptor

Table 3.
Density
for

(fmol/mg Protein,

±SEM)

and Affinity

(nM,

±SEM)

[3H]Spiperone Binding in the Dorsal Striatum of

Preweanling and Adult Rats

Treatment

PD 18 (n~12)
DMSO
EEDQ

(100 mg/kg)

PD 85 (n=12)
DMSO'

%DMSO

(fmol/mg protein)

Kd (nM)

606.lb

(±83.79)

0.140

276.0a

(±63.49)

0.124 (±0.035)

(±0.013)

46%

%DMSO

EEDQ

Bmax

(100 mg/kg)

800.8

(±147.67)

0.114

520.4

(±73.32)

0.289a (±0.067)

(±0.019)

65%

Preweanling and adult rats received bilateral infusions of
DMSO or EEDQ (100 mg/kg) on PD 17 and PD 84, respectively.
Tissue was harvested 24 hr after EEDQ and DMSO infusions.
a Significantly different from DMSO-treated rats of the
same age; b Significantly different from PD 85 rats.
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value of D2-like receptors was significantly increased

■after EEDQ treatment

(Table 3)

P <

[t(10) = 2.51,

0.05].

Ontogenetic Differences
When comparing adult and preweanling rats, adult rats

had significantly more Dl- and D2-like receptor binding
sites than preweanling rats [Age main effects,

F(l,19) = 5.82

P <

0.05; F(l,20) = 5.06,

P <

0.05,

respectively]. At the two ages, EEDQ infusions caused
approximately similar reductions in B^ax values for both

Dl-

(PD 18, 78%; PD 85, 70%) and D2-like (PD 18,

54%;

PD 85, 35%) receptors. In both adult and preweanling rats,
EEDQ seemed to produce a greater decline in Dl- than

D2-like receptors, even though this trend did not reach

statistical significance.
Collectively, these data suggest that Binax values for

both Dl- and D2-like receptors were significantly reduced

after EEDQ infusions in preweanling rat-s, while KD values
were unaltered. In adult rats, however, EEDQ caused a
significant reduction in the B^ax values of Dl-like,
not D2-like, receptors. Interestingly,

KD'

and

values for both

Dl- and D2-like receptors were significantly elevated in

EEDQ-treated adult rats.
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CHAPTER TWELVE
DISCUSSION

The purpose of this thesis was three-fold: a) to

investigate the effects of intrastriatally administered
EEDQ on NPA-mediated locomotor activity in preweanling and

adults rats; b) to determine which dopamine receptor
subtype

(Dl- or D2-like) is responsible for modulating

EEDQ's paradoxical behavioral effects in preweanling rats;

and c) to examine the magnitude of EEDQ-induced Dl- and
D2-like receptor inactivation in both adult and
preweanling rats. It was predicted that: a) microinjecting

EEDQ into the dorsal striatum of adult and preweanling

rats would block NPA-induced locomotor activity; b) both
Dl- and D2-like receptors in the dorsal striatum are
responsible for mediating NPA-induced locomotor

potentiation in preweanling rats; and c)

intrastriatal

infusions of EEDQ were predicted to cause a substantial
reduction of Dl- and D2-like receptor binding sites in
both preweanling and adult rats.

Effects of EEDQ on the NPA-Mediated Locomotor
Activity of Adult Rats

Previous research has shown that systemic
co-administration of the selective Dl- and D2-like

agonists SKF38393 and quinpirole elicits a dose-dependent
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increase in locomotor activity as well as stereotyped

grooming and sniffing

(Braun & Chase,

Kashihara et al.,

1987;

the locomotor activity of adult rats

Costall et al.,

(+)3-PPP increases
(Bradbury et al.,

Similarly,

1981).

Clark & White,

Systemic injections of the

1996) .

non-selective agonists apomorphine or

1984;

1986;

low-dose infusions

of apomorphine or NPA into the dorsal striatum causes both
locomotion and rearing

al.,

1998;

Dias et al.,

(Bordi et al.,
2006;

1994).

adult rats were

(0 or 20 pg)

DMSO infusions. As predicted,

Carrera et

Dickson et al.,

In the current experiment,

microinjected with NPA

1989;

24 hr after EEDQ or

NPA caused a significant

increase in the locomotor activity of DMSO-treated adult
rats;

however,

EEDQ was able to fully attenuate

NPA-induced increases in locomotor activity.

These results

are not surprising considering that systemic EEDQ
treatment blocks NPA-induced locomotion in adults

et al.,

1989).

1989;

Hamblin & Creese,

Therefore,

(Bordi

1983; Meller et al.,

consistent with previous research,

it

appears that reductions in both Dl- and D2-like receptors
due to irreversible inactivation by EEDQ was sufficient to

block the locomotor activating properties of NPA in adult
rats.
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Effects of Dorsal Striatal NPA Infusions on the
Locomotor Activity of Preweanling Rats
In Experiments 2 and 3,

locomotor activity was

assessed after intrastriatal infusions of the
non-selective dopamine agonist NPA.

Treatment with either

10 or 20 pg NPA increased locomotor activity in control
rats.

This result was not surprising because previous

studies have reported that infusing NPA into the dorsal

striatum stimulates locomotion
2011). Additionally,

(Charntikov et al.,

2008,

systemically administering NPA,

well as other non-selective dopamine agonists
cocaine and amphetamine),

as

(i.e.,

increases locomotor activity in

preweanling rats

(McDougall et al.,

Nazarian et al.,

1999).

1995,

1993,

1999;

Effects of EEDQ on the NPA-Induced Locomotor
Activity of Preweanling Rats
Contrary to our predictions,

EEDQ did not attenuate

the NPA-induced locomotor activity of preweanling rats,

instead,

rats,

EEDQ potentiated the locomotor activity of PD 18

while it attenuated the NPA-induced locomotor

activity of adult rats.

Due to these striking results,

investigated which dopamine receptor subtype,
responsible for this effect.

techniques

(i.e.,

if any,

we

was

Using receptor protection

combined SCH23390/sulpiride treatment),

Experiment 2 showed that dopamine receptors are
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responsible for EEDQ's paradoxical behavioral effects in

preweanling animals.

Specifically,

there is a blunting of

NPA-induced locomotion in EEDQ-treated rats pretreated

with SCH23390/sulpiride,

when compared to EEDQ-treated

rats given saline protection

(see Figure 5).

In other

wojrds, NPA-induced locomotor potentiation was only evident
if EEDQ was allowed to alkylate DI- and D2-like receptors.

The purpose of Experiment 3 was to determine which
dopamine receptor subtype

(i.e.,

DI- or D2-like)

is

responsible for the potentiated locomotor response to NPA
that is evident after irreversible antagonism with EEDQ.

NPA

(10 pg)

caused a significant increase in the locomotor

activity of EEDQ-treated rats regardless of individual

receptor protection conditions

(i.e.,

sulpiride pretreatment)(see Figure 6).

SCH23390 or
Therefore,

these

results show that inactivating either DI- or D2-like

receptors -was sufficient to potentiate NPA-induced
locomotor activity.

Only when both DI- and D2-like

receptors were protected from EEDQ

SCH23390/sulpiride treatment)

(i.e.,

after combined

was NPA-induced locomotor

potentiation blocked. Taken together,

these data strongly

suggest that the NPA-induced locomotor potentiation

exhibited by EEDQ-treated preweanling rats is due to the

alkylation of Dl- and D2-like receptors.
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[3H]SCH23390 and [3H] Spiperone Homogenate Ligand
Receptor Binding and Autoradiography

I hypothesized that intrastriatal infusions of EEDQ
(a)

would:

cause a substantial reduction of Dl- and

D2-like receptor binding sites in preweanling and adult
rats,

and

(b)

the decline of Dl- and D2-like receptors

would be greater in adult rats than preweanling rats.

It

has already been established that systemic injections of

EEDQ cause robust declines in both Dl- and D2-like
receptors in preweanling and adult rats
1992;

Giorgi et al.,

1991,

(Crawford et al.,

1992; Meller et al.,

1985).

Data from the present homogenate receptor binding study

'showed that EEDQ infusions caused reductions in the Bmax

values of both Dl(PD 18,

54%;

PD 85,

(PD 18,

35%)

78%;

PD 85,

receptors,

In preweanling

EEDQ caused a significant reduction in the

values of Dl- and D2 -like receptors;
rats,

and D2-like

with the decline being

greater for Dl- than D2-like receptors.

rats,

70%)

whereas,

3max

in adult

EEDQ caused a significant reduction in the ■^max

values of Dl-like,

but not D2-like receptors.

These data

were contrary to my prediction because EEDQ caused a

greater reduction of Dl- and D2-like receptors sites in
preweanling rats than adults.
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The Dl-like receptor autoradiography data complements
the receptor binding data.

EEDQ reduced Dl-like receptors

by 70% in preweanling rats and by 66% in adult rats.

Analysis of the autoradiography data showed that the
D2-like receptor binding sites of preweanling rats were
reduced by 40%,

which was similar to the results obtained

using homogenate ligand binding techniques

54%).

however,

In striking contrast,

(a reduction of

the autoradiography

data showed that there was a far greater reduction of

D2-like receptor binding sites in EEDQ-treated adult rats
(64%)

assay

than what was observed in the homogenate binding
(35%).

When considering D2-like receptors,

the homogenate

ligand binding and autoradiography results are

contradictory to one another.

binding experiment,

In the homogenate ligand

the proportion of D2-like receptor

inactivation in the dorsal striatum is somewhat greater in

preweanling rats than adults

(PD 18,

terms of the autoradiography data,

54%;

PD 85;

35%).

In

EEDQ caused

significantly greater receptor alkylation in adult rats
than preweanling rats

(PD 18,

40%;

PD 85,

64%).

Therefore,

the binding "data show that adult rats have approximately
25% more D2-like receptors than preweanling rats; whereas,

the autoradiography data show that adult rats have
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approximately 50% more D2-like receptors.

Previous studies

employing homogenate binding techniques support the notion

of age-dependent differences in the number of binding
sites.

Specifically,

adult rats have significantly more

■DI- and D2-like receptor binding sites than preweanling

rats

(Crawford et al.,

1992).

In contrast,

two studies

using quantitative autoradiography showed that Dl- and

D2-like receptor binding reached adult levels by
approximately PD 14-21

1994).

Therefore,

(Rao et al.,

1991;

Schambra et al.,

it is not atypical for homogenate ligand

binding and quantitative autoradiography to provide
different patterns of results.

In the current homogenate ligand and autoradiography
experiments,

the same volume of EEDQ

(0.75 pl per side)

was injected into the dorsal striatum of both preweanling
and adult rats. Across ontogeny,
striatum varies,

the size of the dorsal

thus it is possible that more Dl- and

D2-like receptors were inactivated in preweanling rats
than adults due to the relative size of the structure.

Moreover,

it is uncertain whether intrastriatal dispersion

(solubility)

is similar in the two age groups.

Therefore,

it is very likely that more of the dorsal striatum was

left intact in adult rats.

108

Autoradiography is a technique in which the whole

brain is imaged,

but individual structures are of

particular interest.

In this case,

a radiograph of the

tissue is made on a photographic plate from the radiation

emitted by tritium and the distribution of the radiation
is visualized and quantified. A homogenate receptor

binding assay involves gross dissection of a particular

brain structure.

These methodological differences can

account for the discrepancies observed across the two
techniques.

It is likely that during gross dissection,

unaffected areas of the striatum were included in the

final tissue sample.

Instead,

autoradiography is

target-area specific such that a discrete area of the

structure is analyzed.

Paradoxical Actions of EEDQ in
Preweanling Rats

The data from these experiments showed that
intrastriatal EEDQ affects preweanling and adult rats in a

qualitatively different manner.

EEDQ treatment attenuated

NPA-induced -locomotor activity in adult rats.

EEDQ treatment potentiated,

In contrast,

rather than attenuated,

NPA-induced locomotor activity in preweanling rats.

This

paradoxical behavioral pattern gives rise to some
questions:

a)

Why did EEDQ affect the behavior of adult

109

and preweanling rats differently;

and b)

why was the

locomotor activity of preweanling rats potentiated?
Several possible explanations can be used to elucidate

these findings.

First,

it is possible that some other type

of receptor1 was'inactivated and accounted for the
potentiated locomotor response in preweanling rats.
Second,

the proportion of 01- and D2-like receptors

inactivated was not sufficient to diminish the locomotor

activating properties of NPA in preweanling rats.

Third,

a

disproportionate inactivation of Dl- and D2-like receptors
may change the relative excitatory/inhibitory effects of
dopamine agonists on the direct and indirect pathways.

Fourth,

or the lack thereof,

a receptor reserve,

may

account tor the qualitatively different locomotor patterns

observed across ontogeny.

Lastly,

the receptors that were

regenerated or those that remained after alkylation may be

more sensitive in preweanling rats.
Even though EEDQ binds to and inactivates Dl- and
D2-like receptors,

this non-competitive antagonist binds

•to various other receptor types,
muscarinic,

serotonergic,

1985; Arnt & Hyttel,
et al.,

1985;

Sailer et al.,

including ot-adrenergic,

and GABAergic

1988;

Hamblin & Creese,

Miller et al.,

198'9; Vinod,

(Adler et al.,

1983;

1991; Nowak et al.,
Subhash,
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& Srinivas,

Meller

1988;

2001).

Regardless,

the protection experiments clearly show that

dopamine receptors were responsible for the potentiated

locomotor activity exhibited by1 EEDQ-treated preweanling
ratjs 'receiving NPA.

This is evidenced by the fact that the

potentiated locomotor response was attenuated when both

DI- and D2-like receptors were selectively protected
(i.e.,

SCH23390/sulpiride pretreatment)

inactivating effects of EEDQ.

Therefore,

from the
it is unlikely

that our results can be explained by the alkylation of

some other receptor subtype.
Secondly,

it is doubtful whether the inability of

EEDQ to attenuate NPA-induced locomotion can be attributed
to insufficient receptor alkylation.

First,

receptor alkylation should not result in a

locomotor response.

Moreover,

insufficient

potentiated

both the homogenate binding

and autoradiography experiments indicate that there was a
significant reduction in the Dl- and D2-like receptors of

and this reduction is

EEDQ-treated preweanling rats,

comparable to what was observed in adults.

Therefore,

a

significant proportion of Dl- and D2-like receptors were
inactivated in the dorsal striatum of preweanling rats,
i

thus insufficient receptor alkylation cannot account for
the potentiated behavior observed in young animals.
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A third possible explanation for the paradoxical

behavioral effects observed in preweanling rats stems from
the neural organization of Dl- and D2-like receptors.

Stimulating Dl-like receptors activates the direct
(striatonigral)

pathway; whereas,

receptors disinhibits the indirect

pathway

(Gerfen,

1992).

basal ganglia

(striatopallidal)

The downstream components of these

pathways are glutamatergic

(inhibitory)

stimulation of D2-like

and GABAergic

(excitatory)

projections to major output structures of the

(i.e.,

the substantia nigra pars reticulata

and entopeduncular nucleus).

If EEDQ caused a

disproportional inactivation of Dl- and D2-like receptors,

it is possible that an imbalance developed that affected
the relative activity of the direct and indirect pathways.
A change in the activation

(or inhibition)

of either of

these pathways may cause the potentiated locomotor
response observed in preweanling rats;

•

The proposed imbalance of outputs might also affect
feedback loops within the basal ganglia.

The substantia

nigra pars compacta contains dopamine cell bodies,

which

send projections to the dorsal striatum,(nigrostriatal

pathway),

subthalamic nucleus

and globus pallidus

(nigrosubthalamic pathway),

(nigropallidal pathway)(Haber,

In terms of the nigrostriatal pathway,
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1994).

dopamine neurons

synapse on intrinsic GABAergic neurons of the dorsal

striatum (Clarke et al.,

1988). A hypothetical imbalance

of direct and indirect pathway activation would be
expected to differentially affect the firing rate of

compacta dopamine neurons,

thereby indirectly altering the

functioning of the direct and indirect pathways

(i.e.,

cause differential firing of the feedback loop).
Fourth,

the relative size of a "receptor reserve" may

explain why EEDQ differentially affects the behaviors of
preweanling and adult rats.

Receptor reserve theory refers

to the relationship between receptor occupation and
response. According to this model,

a receptor reserve

exists when there are more receptors on the surface of the
cell membrane than are needed for the maximal effect

of a drug.

Theoretically,

(E^x)

if spare receptors are present,

the drug concentration that produces 50% occupancy should

be greater than the concentration that produces 50% of
maximum response.

Evidence suggests the presence of a large receptor

reserve at striatal D2-like autoreceptors in adult rats,
(Furchgott & Burstyn,
Friedhoff,

& Goldstein,

Bohmaker, Adler,

1979),

1967; Meller,

Bohmaker,

1987; Meller,

Friedhoff,

Namba,

Helmer-Matyjek,

& Goldstein,

1986;

Roth,

and a much smaller reserve at D2-like postsynaptic
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receptors

(Meller et al.,

1987; Ruffolo,

article by Gubernator and colleagues

1982). A recent

(2009) utilized

fluorescent false neurotransmitters and multiphoton

imaging to show a preferential synaptic vesicle reserve

for presynaptic D2-like receptors. It has also been
postulated that a receptor reserve exists for postsynaptic
Dl-like receptors, because

(a)

Dl-like receptor

agonist-induced behaviors persisted in EEDQ-treated rats

(Arnt et al.,

1988; Rosengarten et al.,

1989) and (b) a

reduction in Dl-like receptor biding sites in EEDQ-treated
rats did not directly correlate with a decrease in
adelylate cyclase activity (Hess et al.,

1987).

In contrast, because EEDQ-treated preweanling rats

continue to exhibit NPA-induced locomotor activity,

it is

possible that young rats have a larger reserve of Dl- and
D2-like postsynaptic receptors. Consistent with this idea,

our data showed that Dl- and D2-like receptor-mediated
locomotor activity was preserved in EEDQ-treated
preweanling rats even after significant receptor

alkylation. That being said,

there is no corroborating

evidence showing that a large D2-like receptor reserve
exists in preweanling rats. Moreover, a receptor reserve
explanation cannot account for the

potentiated

response exhibited by preweanling rats.
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locomotor

it is possible that EEDQileaves the remaining

Fifth,

i

receptors in a supersensitized state■or,

alternatively,

that the newly generated receptors are supersensitive.

Dopamine receptor supersentivity refers to a phenomenon
where there is a greater than normal physiological,

or biochemical response to a dopamine agonist

behavioral,
(for review,

see Kostrzewa,

1995).

Evidence suggests that
I

dopamine depletion

(e.g.,

after reserpine -or 6-OHDA
I

treatment)

causes a decrease in Dl-like receptor

expression and,

conversely,

receptor’expression

an increase in D2-like

(Gerfen et al.,

1990;

Gerfen,

McGinty,

I

Young 1991; Young et al.,

1986;

see also Gerfen 2003).

Even though there is either a decrease or no change in
I

Dl--like receptor expression

(Gerfen et al., .1990;
i

Marshall,

Navarrete,

& Joyce,

1989),,a supersensitive

response is evident, after Dl-like receptor stimulation

(Berke,

Paletzki, Aronson,

et al.,

1995;

& Gerfen,

Hyman,

Robertson, Vincent,

1996).

& Gerfen,
& Fibiger,

1998;
1990;

Gerfen
Steiner

Dopamine depletion can also cause

receptor supersensitivity in preweanling rats as evidenced

by a potentiated behavioral response!to dopaminergic drugs
(Farley et al.,

2006).

Not surprisingly,

EEDQ significantly reduces dopamine

content in the dorsal striatum at PD 17 and PD 90
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(Crawford et al.,

1992,

1994a).

Reduced dopamine levels

can lead to receptor inactivation and,

receptor supersensitivity

al.,

1996).

(Berke et al.,

Robertson et al.,

1995;

consequently,

1990;

1998;

Gerfen et

Steiner & Gerfen,

Receptor turnover rates vary across ontogeny,

with

receptor repopulation occurring at a more rapid pace in

preweanling rats than adults

al.,

1992).

El-Ghundi,

Palmiter,

Kula et

1984;

It is likely that newly synthesized receptors

are supersensitive
Srivastava,

(Leff et al.,

(see Seeman,

Bhardwaj,
O'Dowd,

Grandy,

George,

& Tallerico,

Weinshenker,

Premont,

Perreault,

2005);

thus,

Quirion,

Sotnikova,
Mannisuo,

Boksa,

Robinson,

with quicker receptor

repopulation it is possible that EEDQ-treated preweanling
rats have a larger complement of supersensitive receptors

than adult rats.

If so,

preweanling rats may show a

potentiated locomotor response because of an abundance of
supersensitive Dl- and D2-like receptors.

Conclusion

In conclusion,

data from this thesis adds to previous

research showing that dopaminergic compounds can affect
the behaviors of preweanling and adult rats differently.

The present results inducate that NPA does not increase
the locomotor activity of EEDQ-treated adults; whereas,

EEDQ-treated preweanling rats show a potentiated locomotor
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response after NPA treatment.

Importantly,

this

potentiated locomotion is due to the alkylation of Dl- and
D2-like receptors,

and not some other receptor type.

Homogenate ligand binding and autoradiography experiments
showed that EEDQ caused a significant reduction in the

dorsal striatal Dl- and D2-like receptors of preweanling

rats.

I think that the most plausible explanation for the

potentiated locomotor response observed in EEDQ-treated
preweanling rats stems from age-dependent differences in

Dl- and D2-like receptor' supersensitivity.

Receptor

turnover is greater in preweanling rats and it possible
that NPA is stimulating an abundance of supersensitized

receptors,

thereby resulting in a potentiated locomotor

response.
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APPENDIX A

CANNULA PLACEMENT SCHEMATICS

118

B

A

0.70

0.48

0.20

-0.26

-0.30

Schematic representations of cannula placements in the dorsal striatum of

(A) adult (Experiment 1) and (B) preweanling rats (Experiment 2 and 3). In all
cases, numbers on the right indicate distance (mm) from Bregma using

coordinates from the rat brain atlas of Paxinos and Watson (1998).
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APPENDIX B
AUTORADIOGRAMS:

PREWEANLING RATS

120

DMSO

EEDQ

Representative autoradiograms of [3H]SCH23390 and [3H]spiperone binding
after bilateral infusions of EEDQ and DMSO into the dorsal striatum on PD

17.
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APPENDIX C
AUTORADIOGRAMS:

122

ADULT RATS

EEDQ

DMSO

D1

Representative autoradiograms of [3H]SCH23390 and [3H]spiperone binding
after bilateral infusions of EEDQ and DMSO into the dorsal striatum on PD

84.
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